{"gene":"CLCN3","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1995,"finding":"CLCN3 encodes a 760-amino-acid protein belonging to the voltage-gated chloride channel (ClC) family, with high sequence similarity to GEF1 (a yeast integral membrane protein involved in respiration and iron-limited growth), indicating conserved fundamental function; the gene is expressed primarily in neuroectoderm-derived tissues, with high hippocampal, olfactory cortex, and olfactory bulb expression.","method":"Molecular cloning, sequence analysis, Northern blot/in situ hybridization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — original cloning paper with sequence/structural characterization; single lab, foundational characterization","pmids":["7665160"],"is_preprint":false},{"year":1999,"finding":"ClC-3 volume-regulated chloride channel activity is controlled by phosphorylation/dephosphorylation: PKC activation closes the channel, PKC inhibition opens it, and serine51 in the intracellular N-terminus (within a consensus PKC phosphorylation site) is the critical volume sensor residue.","method":"Site-directed mutagenesis, patch-clamp electrophysiology in cardiac cells and NIH/3T3 cells overexpressing ClC-3","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with patch-clamp functional validation; replicated in native and recombinant systems","pmids":["9874688"],"is_preprint":false},{"year":2000,"finding":"When expressed in CHO-K1 cells, ClC-3 produces Cl->I- selective, extremely outward-rectifying currents insensitive to NPPB, DIDS, and phorbol esters and not activated by osmotic swelling—properties identical to ClC-5 and distinct from endogenous swelling-activated channels, demonstrating ClC-3 is not the swelling-activated channel under all conditions.","method":"Transient transfection of rat ClC-3 into CHO-K1 cells, whole-cell patch-clamp electrophysiology, pharmacological profiling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — rigorous biophysical characterization with multiple pharmacological controls in a defined expression system","pmids":["10973952"],"is_preprint":false},{"year":2001,"finding":"CaMKII phosphorylation regulates the plasma membrane expression and activity of hCLC-3: intracellular infusion of autonomously active CaMKII increased ClC-3 currents ~22-fold in stably transfected tsA cells, and mutation of glycine 280 to glutamic acid in the pore region changed anion selectivity from I->Cl- to Cl->I-.","method":"Stable transfection of hCLC-3 in tsA cells, whole-cell patch-clamp with CaMKII infusion, AIP inhibitor, pore-region mutagenesis, surface biotinylation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution with kinase infusion, specific inhibitor, and mutagenesis","pmids":["11274166"],"is_preprint":false},{"year":2001,"finding":"Intracellular dialysis of anti-ClC-3 antibody completely abolished expressed ClC-3 currents and native volume-sensitive outwardly rectifying anion channel (VSOAC) currents in guinea-pig cardiac cells, canine pulmonary arterial smooth muscle cells, and Xenopus oocytes, establishing ClC-3 as a major molecular entity of VSOACs in these cell types.","method":"Intracellular dialysis of polyclonal anti-ClC-3 antibody during whole-cell patch-clamp recording; antigen preabsorption controls","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1/2 — functional antibody inhibition with rigorous antigen-preabsorption specificity controls, replicated across multiple cell types","pmids":["11230516"],"is_preprint":false},{"year":2002,"finding":"Heterologous ClC-3 expression in CHO-K1 and Huh-7 cells promotes lysosomal acidification: overexpression creates large acidic vesicles co-labeled with LAMP-1, LAMP-2, and cathepsin D; vesicle formation requires both V-ATPase proton pumping and ClC-3 Cl- channel activity (blocked by E224A mutant), consistent with ClC-3 providing charge neutralization for lysosomal acidification.","method":"Heterologous overexpression, bafilomycin treatment, E224A mutagenesis, organelle pH measurement, co-localization with lysosomal markers","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and multiple orthogonal methods confirming lysosomal identity and functional dependence","pmids":["11997263"],"is_preprint":false},{"year":2002,"finding":"CLC-3-deficient (Clcn3-/-) mice exhibit elevated endosomal pH, progressive neurodegeneration of hippocampus and retina, and lysosomal accumulation of mitochondrial F1F0 ATPase subunit c, phenocopying neuronal ceroid lipofuscinosis, establishing ClC-3 as required for endosomal acidification and lysosomal protein degradation.","method":"Targeted gene disruption (Clcn3-/- mice), endosomal pH measurement, immunohistochemistry, Western blot, histological analysis","journal":"Genes to cells","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with multiple orthogonal functional readouts; replicated by independent lab","pmids":["12059962"],"is_preprint":false},{"year":2002,"finding":"ClC-3 antisense oligonucleotides significantly reduce volume-sensitive osmolyte and anion channel (VSOAC) density and impair regulatory volume decrease in HeLa cells and Xenopus oocytes, supporting ClC-3 as a fundamental molecular component of VSOACs.","method":"ClC-3 antisense transfection/injection, semi-quantitative and real-time PCR, immunoblot, hypotonic whole-cell recording, cell volume measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — antisense knockdown with multiple orthogonal endpoints in two cell systems; single lab","pmids":["12183454"],"is_preprint":false},{"year":2002,"finding":"ClC-3 is sorted to synaptic vesicles via an AP-3-dependent trafficking pathway; ClC-3 levels in synaptic vesicles and hippocampal mossy fiber terminals are reduced in AP-3-deficient mocha mice; in PC-12 cells ClC-3 trafficking to synaptic-like microvesicles is brefeldin A-sensitive; increased ClC-3 expression enhances vesicular zinc transport in concert with ZnT3, with which it co-segregates.","method":"AP-3-deficient mocha mouse model, subcellular fractionation, immunohistochemistry, brefeldin A treatment, ZnT3 co-fractionation and functional zinc transport assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in genetic model plus functional vesicular transport readout","pmids":["15073168"],"is_preprint":false},{"year":2002,"finding":"ClC-3B, a novel C-terminal splice variant of ClC-3, interacts with the PDZ domain of EBP50 via a C-terminal PDZ-binding motif; co-transfection of ClC-3B with EBP50 redistributes ClC-3B to the leading edge of membrane ruffles and produces a remarkable increase in ORCC currents that can be activated by CFTR via PKA-dependent pathway.","method":"Cloning, in vitro and in vivo binding assays (GST pulldown, co-IP), immunofluorescence, whole-cell patch-clamp","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1/2 — biochemical interaction assays combined with electrophysiological functional readout and localization","pmids":["11967229"],"is_preprint":false},{"year":2004,"finding":"CaMKII phosphorylates the N-terminus of CLC-3 in vitro, and serine 109 (S109) in the N-terminal CaMKII consensus sequence is critical for CaMKII-dependent Cl- conductance at the plasma membrane; S109A mutation abolishes the CaMKII-activated current.","method":"In vitro kinase phosphorylation assay, site-directed mutagenesis (S109A), whole-cell patch-clamp with CaMKII infusion in smooth muscle cells and HT29 cells, CLC-3-/- cells as negative control","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus mutagenesis with electrophysiological validation; genetic null control","pmids":["14754994"],"is_preprint":false},{"year":2004,"finding":"Neuronal excitability is modulated by CLC-3 at postsynaptic sites: CaMKII-activated CLC-3 Cl- conductance enhances NMDA receptor-mediated miniature EPSPs in a Cl--dependent fashion; CLC-3 co-immunoprecipitates with NMDA receptors and is localized at postsynaptic sites by electron microscopy and surface biotinylation; this conductance is absent in clc-3-/- mice.","method":"Patch-clamp electrophysiology in hippocampal neurons, surface biotinylation, immunohistochemistry, electron microscopy, co-immunoprecipitation, clc-3-/- knockout comparison","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1/2 — multiple orthogonal methods including genetic null, co-IP, EM, and electrophysiology","pmids":["17046694"],"is_preprint":false},{"year":2007,"finding":"ClC-3 overexpression in HEK293T cells induces pH-dependent outwardly rectifying currents with reversal potential shifts of ~10 mV/decade pH change and ~48 mV/decade Cl- change (non-Nernstian), indicating coupled Cl-/H+ antiport; E224A mutation removes pH sensitivity and restores Nernstian Cl- dependence, identifying E224 as the extracellular glutamate gate governing coupling.","method":"Heterologous overexpression in HEK293T, whole-cell patch-clamp, extracellular pH manipulation, E224A mutagenesis, reversal potential analysis","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of gating residue with quantitative biophysical characterization establishing Cl-/H+ antiport mechanism","pmids":["17977943"],"is_preprint":false},{"year":2007,"finding":"ClC-3 is primarily an intracellular transport protein that traffics through the plasma membrane via clathrin-mediated endocytosis; the N-terminal dileucine acidic cluster (amino acids 13-19) interacts directly with clathrin (demonstrated by co-IP and GST pulldown), and alanine replacement of this motif reduces endocytosis, increases plasma membrane expression, and abolishes clathrin binding.","method":"Pulse-labeling, surface biotinylation, immunofluorescence, co-immunoprecipitation, GST pulldown, alanine-substitution mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1/2 — biochemical interaction assays with mutagenesis and trafficking quantification; multiple orthogonal methods","pmids":["17652080"],"is_preprint":false},{"year":2007,"finding":"In vascular smooth muscle cells, Nox1 (NADPH oxidase subunit) and p22phox co-immunoprecipitate with early endosomal markers; ClC-3 co-localizes with Nox1 in early endosomes and is required for cytokine (TNF-α, IL-1β)-induced intraendosomal ROS production and subsequent NF-κB activation, functioning as a charge compensator for Nox1-generated electron flow across the endosomal membrane.","method":"Co-immunoprecipitation, co-localization by confocal microscopy, ROS measurement, NF-κB reporter assay, shRNA knockdown of ClC-3","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with functional ROS and NF-κB readouts, multiple orthogonal approaches","pmids":["17673675"],"is_preprint":false},{"year":2007,"finding":"Hypotonic activation of the short ClC-3 isoform (sClC-3) requires direct interaction between its cytosolic C-terminal tail and filamentous (F-) actin, but not G-actin; the F-actin binding region maps to amino acids 690-760, and peptides disrupting this interaction reduce VSOAC current density by ~40-60% upon intracellular dialysis.","method":"GST pulldown/co-sedimentation assays with F-actin, truncation mapping, synthetic peptide competition, intracellular dialysis with peptides + patch-clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstituted binding with domain mapping plus functional electrophysiological validation via peptide competition","pmids":["17442672"],"is_preprint":false},{"year":2008,"finding":"ClC-3 is required for CaMKII-dependent Cl- currents in glioma cells; CaMKII co-localizes and co-immunoprecipitates with ClC-3 in glioma cells and in GBM patient biopsies; shRNA knockdown of ClC-3 eliminates CaMKII-dependent currents, and inhibition of CaMKII reduces glioma invasion to the same extent as direct ClC-3 inhibition.","method":"Co-immunoprecipitation, whole-cell patch-clamp with CaMKII infusion, shRNA knockdown, AIP inhibitor, invasion assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with functional KD and invasion readouts; replicated in patient tissue","pmids":["20139089"],"is_preprint":false},{"year":2008,"finding":"ClC-3 channels are required for premitotic cytoplasmic condensation (PMC) during cell division: patch-clamp shows upregulation of Cl- currents at M phase; ClC-3 is present on the plasma membrane and at the mitotic spindle (co-localization and co-IP); shRNA knockdown of ClC-3 reduces M-phase Cl- currents, slows PMC rate, and impairs DNA condensation.","method":"Patch-clamp electrophysiology at defined cell cycle stages, co-immunoprecipitation, immunofluorescence co-localization, shRNA knockdown","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches with specific cell-cycle-dependent functional readouts and genetic KD","pmids":["18784301"],"is_preprint":false},{"year":2008,"finding":"Ins(3,4,5,6)P4 inhibits ClC-3-mediated Cl- conductance at the plasma membrane and raises intra-endosomal pH (inhibits ClC-3 Cl-/H+ exchange in endosomes), and also inhibits endogenous ClC-3 conductance in postsynaptic membranes of neonatal hippocampal neurons, identifying Ins(3,4,5,6)P4 as a physiological regulator of ClC-3.","method":"Heterologous expression in HEK293 cells, whole-cell patch-clamp, fluorescence ratio imaging of endosomal pH with FITC-transferrin, cell-permeant Ins(3,4,5,6)P4 analog","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 1/2 — direct functional assays in plasma membrane and endosomal contexts with specific membrane-permeant agonist, replicated across compartments","pmids":["18951024"],"is_preprint":false},{"year":2008,"finding":"ClC-3 localizes to endosomes and synaptic-like microvesicles (not large dense-core vesicles) in adrenal chromaffin and pancreatic beta cells; Clcn3-/- chromaffin cells show decreased exocytosis of large dense-core vesicles (capacitance measurements and amperometry), indicating an indirect role of ClC-3 in LDCV exocytosis through endosomal trafficking steps.","method":"Immunohistochemistry, subcellular fractionation, capacitance measurements, carbon-fiber amperometry, Clcn3-/- knockout mice","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with direct exocytosis measurement and precise subcellular fractionation","pmids":["18923035"],"is_preprint":false},{"year":2009,"finding":"ClC-3 Cl-/H+ exchange becomes uncoupled at low extracellular pH: between pH 8.2-6.2 protons shift the reversal potential, but below pH 6.2 Cl- transport and H+ transport uncouple; at pH 4.0 ClC-3 behaves as a purely anion-selective channel; extracellular cysteine residues (103-130 region) mediate MTSES-sensitivity; an E224A mutant lacks pH sensitivity and restores Nernstian Cl- dependence.","method":"Adenoviral ClC-3 expression in HEK293, whole-cell patch-clamp, pH and Cl- concentration manipulation, MTSES modification, mutagenesis (E224A, C103_P130del), shRNA knockdown of endogenous ClC-3","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis and chemical modification with quantitative biophysical analysis of coupling mechanism","pmids":["19926787"],"is_preprint":false},{"year":2009,"finding":"ClC-3 is expressed on insulin secretory granules in pancreatic beta cells and is required for granule priming: Clcn3-/- beta cells show >60% reduction in glucose- and sulfonylurea-evoked insulin secretion, ~80% reduction in depolarization-evoked exocytosis (capacitance measurements), and 44% reduction in proton transport across granule membranes; ClC-3 on LDCVs was confirmed by immunoblot, immunostaining, and immunoelectron microscopy.","method":"Clcn3-/- knockout mice, insulin secretion assay, single-cell capacitance measurements, vesicle proton transport assay, immunoblot/immunostaining/immuno-EM of purified LDCVs","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1/2 — genetic knockout with multiple quantitative functional assays and direct subcellular localization to LDCVs by immuno-EM","pmids":["19808023"],"is_preprint":false},{"year":2010,"finding":"ClC-3 is a Cl-/H+ antiporter with biophysical properties similar to ClC-4 and ClC-5; an N-terminal retention signal keeps endogenous ClC-3 off the plasma membrane; N-terminal mutation (ClC-313-19A) allows surface expression and reveals outwardly rectifying coupled Cl-/H+ exchange; ClC-3 also exhibits large voltage-dependent nonlinear capacitance exceeding that of ClC-4 and ClC-5, and mutations of the proton glutamate decrease transport but increase capacitance.","method":"Electrophysiology combined with fluorescence pH measurements, N-terminal mutagenesis, proton glutamate mutagenesis, mathematical modeling","journal":"ACS chemical neuroscience","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and direct fluorescence pH transport assays; mathematical modeling of mechanism","pmids":["23509947"],"is_preprint":false},{"year":2010,"finding":"TNF-α activates swelling-activated Cl- current (ICl,swell) in vascular smooth muscle cells via ClC-3-dependent endosomal H2O2 production: ICl,swell was absent in ClC-3 null cells, was activated by H2O2, was blocked by catalase, and was abolished by dominant-negative Rab5 or Rab11 (disrupting endosome trafficking), establishing a mechanistic link between ClC-3 endosomal ROS generation and ICl,swell activation.","method":"Perforated patch-clamp, ClC-3 null mouse VSMCs, catalase treatment, dominant-negative Rab5/Rab11 expression, H2O2 challenge","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1/2 — genetic null + pharmacological + dominant-negative trafficking disruption with defined electrophysiological readouts","pmids":["20479003"],"is_preprint":false},{"year":2011,"finding":"Presynaptic CLC-3 on GABAergic synaptic vesicles is required for normal inhibitory transmission in hippocampus: Clcn3-/- slices show decreased amplitude and frequency of miniature IPSCs; CLC-3 co-localizes with VGAT in CA1; Cl--dependent acidification of inhibitory synaptic vesicles is markedly reduced in Clcn3-/- neurons, indicating CLC-3 enables neurotransmitter loading by supporting vesicle acidification.","method":"Hippocampal slice electrophysiology, immunofluorescence co-localization with VGAT, vesicle acidification assay with Cl- dependence, Clcn3-/- knockout","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with electrophysiological and direct vesicle acidification assays; high-impact journal","pmids":["21378974"],"is_preprint":false},{"year":2011,"finding":"CaMKII-dependent kinase activation of ClC-3 drives cytoplasmic condensation (PMC) during mitotic cell rounding in human glioma cells; time-lapse microscopy shows PMC is reduced by ClC-3 shRNA knockdown or KN-93 (CaMKII inhibitor); CaMKII activates ClC-3 Cl- currents in dividing cells, leading to Cl- efflux-driven volume decrease.","method":"Time-lapse microscopy, patch-clamp electrophysiology at mitosis, shRNA knockdown of ClC-3, CaMKII inhibitor KN-93","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 2 — direct live imaging of cell volume with genetic and pharmacological perturbation and electrophysiological confirmation","pmids":["22049206"],"is_preprint":false},{"year":2011,"finding":"CLC-3 co-localizes with NMDA receptors at postsynaptic sites and its phosphorylation by CaMKII is required for its regulatory function in long-term potentiation (LTP): CLC-3 knockout increases LTP by ~40% above wild type; a decoy peptide of the CaMKII phosphorylation site on CLC-3 mimics the knockout effect on LTP, demonstrating that phosphorylated CLC-3 limits synaptic potentiation.","method":"Hippocampal slice LTP recordings, CLC-3 knockout mice, decoy phosphorylation peptide intracellular infusion","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout combined with phospho-site decoy peptide in defined electrophysiological assay","pmids":["23165767"],"is_preprint":false},{"year":2012,"finding":"ClC-3 deficiency results in larger synaptic vesicles and increased amplitude/frequency of miniature EPSCs and action-potential-evoked EPSCs in hippocampal neurons; low-affinity AMPA receptor antagonist γ-DGG reduces quantal size more in WT than Clcn3-/- neurons, indicating ClC-3 controls glutamate loading into synaptic vesicles and affects release probability, with excessive glutamate release as a likely basis of neurodegeneration.","method":"Whole-cell patch-clamp in cultured hippocampal neurons from Clcn3-/- mice, γ-DGG and NBQX receptor antagonism, electron microscopy of synaptic vesicle size, measurement of readily releasable pool","journal":"Frontiers in cellular neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with electrophysiology, pharmacological dissection, and structural EM; multiple orthogonal endpoints","pmids":["24904288"],"is_preprint":false},{"year":2013,"finding":"Bradykinin-induced glioma chemotaxis requires CaMKII-dependent activation of ClC-3: bradykinin raises intracellular Ca2+, activates Ca2+-dependent Cl- currents via CaMKII→ClC-3 and KCa3.1; pharmacological CaMKII inhibition or shRNA knockdown of ClC-3 each inhibit Ca2+-activated Cl- currents and abolish bradykinin-induced chemotaxis; ClC-3 and KCa3.1 co-localize to invading processes of glioma cells.","method":"Fura-2 Ca2+ imaging, perforated patch-clamp electrophysiology, CaMKII inhibition, ClC-3 shRNA knockdown, brain slice invasion assay, immunofluorescence co-localization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods linking Ca2+ signaling through CaMKII to ClC-3 activity and functional invasion readout","pmids":["23345219"],"is_preprint":false},{"year":2014,"finding":"ClC-3 deficiency promotes intestinal epithelial cell apoptosis via the mitochondrial pathway and impairs Paneth cell function; ClC-3 interacts with voltage-dependent anion channel 1 (VDAC1, a regulator of mitochondrial cytochrome c release) by co-immunoprecipitation; DSS treatment decreases the ClC-3/VDAC1 interaction; ClC-3-/- mice show increased susceptibility to experimental colitis.","method":"Clcn3-/- knockout mice, dextran sulfate sodium/TNBS colitis models, co-immunoprecipitation of ClC-3 with VDAC1, apoptosis assays, Paneth cell counting, antimicrobial peptide expression","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with co-IP and multiple functional apoptosis/cellular readouts","pmids":["24440986"],"is_preprint":false},{"year":2015,"finding":"Three ClC-3 splice variants (ClC-3a, -3b, -3c) differ in subcellular targeting but mediate identical Cl-/H+ exchange: ClC-3a/b target to late endosomes/lysosomes via N-terminal dileucine-like motifs; ClC-3c targets to recycling endosomes via a novel N-terminal isoleucine-proline (IP) motif; all three produce equivalent outwardly rectifying Cl- currents with capacitive components.","method":"Identification of splice variants in mouse brain, immunofluorescence co-localization with compartment markers, site-directed mutagenesis of trafficking motifs, whole-cell patch-clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1/2 — multiple isoforms characterized with mutagenesis of targeting motifs and electrophysiological functional validation","pmids":["26342074"],"is_preprint":false},{"year":2016,"finding":"Angiotensin II-induced Cl- current in vascular smooth muscle cells requires ClC-3 channel phosphorylation at threonine 532 by Rho-kinase 2 (ROCK2): ROCK2 co-immunoprecipitates with ClC-3 N- and C-termini; ROCK2 siRNA abolishes AngII-induced current; T532D phosphomimetic mutant potentiates, while T532A abolishes, AngII-induced current and VSMC migration; AngII-induced cerebrovascular remodeling is reduced in ClC-3 null mice.","method":"Co-immunoprecipitation, N/C-terminal truncation constructs, site-directed mutagenesis (T532D, T532A), ROCK2 siRNA, whole-cell patch-clamp, transwell migration assay, ClC-3 null mice","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis + co-IP + genetic null with functional electrophysiology and migration readouts","pmids":["26562480"],"is_preprint":false},{"year":2017,"finding":"ClC-4 sorting to endosomal compartments depends on its preferred heterodimerization with ClC-3: ClC-4 expressed alone is retained in ER; co-expression with ClC-3 splice variants redirects ClC-4 to late endosomes/lysosomes or recycling endosomes depending on which ClC-3 isoform is present; in Clcn3-/- astrocytes, ClC-4 is retained in the ER; high-resolution clear native PAGE shows ClC-3-ClC-4 heterodimers are more stable than ClC-4 homodimers.","method":"Heterologous co-expression, immunofluorescence co-localization, Clcn3-/- astrocytes, high-resolution clear native gel electrophoresis for oligomeric state analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic null confirmation plus biochemical oligomerization analysis with defined functional trafficking readout","pmids":["28972156"],"is_preprint":false},{"year":2018,"finding":"Detailed mechanistic analysis of ClC-3 Cl-/H+ exchange: the external gating glutamate E224 and central tyrosine anion gate Y572 act as anion barriers and interact to form a 'closed gate' conformation that maintains coupling; Y572S removal increases uncoupled anion current and impairs coupling; M531A mutation predicted to improve water-wire H+ supply improves exchange efficiency; external protons (pH 5.0) inhibit transport and shift gating charge; ClC-3 has lower transport efficiency but identical coupling ratio compared to ClC-5.","method":"Plasma membrane-localized ClC-3, whole-cell patch-clamp, pH manipulation, gating charge (Q) analysis, cytoplasmic alkalization rate measurement, multiple mutagenesis (E224A, Y572S, Y572F, M531A)","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis of multiple gating residues with quantitative biophysical analysis of coupling, Q movement, and transport rates","pmids":["29917234"],"is_preprint":false},{"year":2018,"finding":"ClC-3 Cl-/H+ transporter regulates HER2 transcription in HER2-positive breast cancer cells through STAT3 signaling: ClC-3 siRNA knockdown in MDA-MB-453 cells markedly represses HER2 transcription and decreases STAT3 phosphorylation while increasing AKT phosphorylation.","method":"siRNA knockdown of ClC-3, qPCR and Western blot for HER2, phospho-AKT and phospho-STAT3 analysis, kinase inhibitors (AZD5363, everolimus, 5,15-DPP)","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2/3 — siRNA with pathway readouts, single lab, limited mechanistic detail on direct ClC-3/STAT3 link","pmids":["29949674"],"is_preprint":false},{"year":2018,"finding":"ClC-3 promotes angiotensin II-induced NADPH oxidase activation and ROS production in endothelial cells by facilitating Nox2/p22phox expression and p38 MAPK-dependent phosphorylation and membrane translocation of p47phox/p67phox to form the Nox2 NADPH oxidase complex.","method":"ClC-3 knockdown/overexpression in HUVECs, NADPH oxidase activity assay, ROS measurement, p47phox/p67phox membrane fractionation, p38 MAPK inhibitor SB203580, Western blot for complex components","journal":"Acta pharmacologica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function and loss-of-function with mechanistic dissection of NADPH oxidase complex formation; single lab","pmids":["29977005"],"is_preprint":false},{"year":2021,"finding":"De novo heterozygous missense variants and homozygous loss-of-function variants in CLCN3 cause neurodevelopmental disorders with GDD/ID and structural brain abnormalities; two missense variants (p.Ile607Thr and p.Thr570Ile) show increased currents at negative cytoplasmic voltages and loss of inhibition by luminal acidic pH in Xenopus oocytes and mammalian cells, demonstrating gain-of-function alterations in Cl-/H+ exchange gating.","method":"Whole-exome sequencing, electrophysiological characterization of variants in Xenopus oocytes and mammalian cells, clinical neuroimaging (MRI)","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1/2 — direct functional electrophysiological characterization of patient variants in established expression systems; links specific variant mechanisms to human disease","pmids":["34186028"],"is_preprint":false},{"year":2012,"finding":"VSMC migration requires ClC-3-dependent Ca2+-activated Cl- current (ICl.Ca): ICl.Ca is reduced ~50% in ClC-3 null VSMCs; the ClC-3-dependent component is activated by CaMKII (inhibited by KN-93) and inhibited by Ins(3,4,5,6)P4; ClC-3 null VSMCs show ~50% reduced migration in transwell assays; wild-type cell migration is reduced by niflumic acid, KN-93, or Ins(3,4,5,6)P4 but not in ClC-3 null cells.","method":"Whole-cell patch-clamp in WT and ClC-3 null VSMCs, CaMKII inhibitor, Ins(3,4,5,6)P4, transwell migration assay, Clcn3-/- genetic knockout","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — genetic null combined with pharmacological dissection linking specific kinase/second-messenger regulation to ClC-3-dependent migration","pmids":["23150504"],"is_preprint":false},{"year":2008,"finding":"Cardiac-specific inducible ClC-3 knockout eliminates native VSOAC currents in atrial and ventricular myocytes and causes myocardial hypertrophy and heart failure, establishing ClC-3 as the key molecular component of native VSOACs in mammalian heart and demonstrating a cardioprotective role.","method":"Inducible cardiac-specific Cre/lox ClC-3 knockout mice, echocardiography, patch-clamp of isolated cardiomyocytes, qRT-PCR and Western blot for ClC-3 loss","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — inducible, tissue-specific genetic knockout with direct electrophysiological and cardiac function readouts","pmids":["19615374"],"is_preprint":false},{"year":2022,"finding":"HNRNPK is identified as a transcription factor that directly binds the CLCN3 promoter (binding motif 'GCGAGG', binding site -538/-248 bp) and drives CLCN3 transcription; HNRNPK knockdown suppresses CLCN3 promoter activity and mRNA/protein expression; reduced extracellular ClC-3 secretion from HNRNPK-silenced cells inhibits cancer-associated fibroblast (CAF) activation and TGF-β1 production.","method":"5'-biotin-labeled promoter pulldown assay to identify HNRNPK, promoter activity reporter assays, shRNA knockdown, RNA-seq, xenograft mouse model, CAF isolation and functional assays","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter pulldown identifies transcription factor with mutagenesis of binding site and functional reporter assay; single lab","pmids":["36439880"],"is_preprint":false}],"current_model":"CLCN3 encodes an intracellular Cl-/H+ antiporter (ClC-3) that primarily localizes to endosomes, lysosomes, synaptic vesicles, and insulin secretory granules via AP-3- and clathrin-dependent trafficking (directed by N-terminal dileucine and isoform-specific targeting motifs); it provides charge compensation for V-ATPase-driven organelle acidification critical for lysosomal degradation, synaptic vesicle neurotransmitter loading (both GABAergic and glutamatergic), and insulin granule priming; at the plasma membrane, ClC-3 is activated by CaMKII phosphorylation at S109 (and regulated by ROCK2 at T532 and PKC at S51) to mediate volume-sensitive Cl- efflux supporting cell volume regulation, premitotic condensation, and cell migration; ClC-3 also functions within signaling endosomes to provide charge neutralization for Nox1 NADPH oxidase-generated electron flow, enabling ROS-dependent NF-κB activation downstream of TNF-α/IL-1β; loss-of-function variants in humans cause neurodevelopmental disorders, while gain-of-function variants alter Cl-/H+ coupling gating."},"narrative":{"teleology":[{"year":1995,"claim":"Cloning of CLCN3 established it as a member of the voltage-gated chloride channel family with predominant expression in neuroectoderm-derived tissues, raising the question of its physiological ion transport role.","evidence":"Molecular cloning, sequence analysis, and Northern blot/in situ hybridization in human tissues","pmids":["7665160"],"confidence":"Medium","gaps":["No functional electrophysiology performed","Endogenous subcellular localization not determined"]},{"year":1999,"claim":"Identification of PKC phosphorylation at S51 as a volume-sensing regulatory mechanism and CaMKII as an activator established that ClC-3 channel activity is under bidirectional kinase control at the plasma membrane.","evidence":"Site-directed mutagenesis and patch-clamp in cardiac cells and NIH/3T3 overexpression systems; CaMKII infusion in tsA cells with surface biotinylation","pmids":["9874688","11274166"],"confidence":"High","gaps":["Whether CaMKII phosphorylation site was identified at this stage","Physiological context of dual kinase regulation unclear"]},{"year":2000,"claim":"Heterologous expression revealed ClC-3 produces extremely outward-rectifying, swelling-insensitive currents identical to ClC-5, challenging the simple model that ClC-3 is the canonical volume-sensitive anion channel.","evidence":"Transient transfection in CHO-K1 cells with whole-cell patch-clamp and pharmacological profiling","pmids":["10973952"],"confidence":"High","gaps":["Apparent conflict with endogenous VSOAC data not resolved","Cell-type-specific differences in ClC-3 function not addressed"]},{"year":2002,"claim":"Multiple convergent studies established ClC-3 as a predominantly intracellular protein required for endosomal/lysosomal acidification: Clcn3⁻/⁻ mice showed elevated endosomal pH, neuronal ceroid lipofuscinosis-like neurodegeneration, and lysosomal storage, while overexpression promoted LAMP-1-positive acidic vesicle formation dependent on the E224 gating glutamate.","evidence":"Targeted gene disruption in mice with endosomal pH measurement and histology; heterologous overexpression with E224A mutagenesis and lysosomal marker co-localization","pmids":["12059962","11997263"],"confidence":"High","gaps":["Mechanism of V-ATPase coupling not biochemically defined","Relative contribution of Cl⁻ channel vs. antiporter mode not yet resolved"]},{"year":2002,"claim":"AP-3-dependent sorting to synaptic vesicles was demonstrated using the mocha mouse model, linking ClC-3 trafficking to presynaptic function and vesicular zinc transport alongside ZnT3.","evidence":"AP-3-deficient mocha mice, subcellular fractionation, brefeldin A treatment, ZnT3 co-fractionation and zinc transport assay in PC-12 cells","pmids":["15073168"],"confidence":"High","gaps":["Direct role in neurotransmitter loading not yet tested","Relative contribution of AP-3 vs. clathrin pathways not quantified"]},{"year":2004,"claim":"Identification of S109 as the specific CaMKII phosphorylation site responsible for plasma membrane Cl⁻ conductance activation provided a defined molecular mechanism for kinase-dependent ClC-3 regulation.","evidence":"In vitro kinase assay, S109A mutagenesis, whole-cell patch-clamp with CaMKII infusion in smooth muscle and HT29 cells, Clcn3⁻/⁻ negative control","pmids":["14754994"],"confidence":"High","gaps":["Whether S109 phosphorylation alters trafficking versus gating not distinguished","In vivo phosphorylation stoichiometry unknown"]},{"year":2007,"claim":"Several key mechanistic features were resolved simultaneously: (1) ClC-3 operates as a coupled Cl⁻/H⁺ antiporter gated by the E224 glutamate, (2) clathrin-mediated endocytosis via an N-terminal dileucine motif keeps ClC-3 predominantly intracellular, (3) ClC-3 in signaling endosomes provides charge neutralization for Nox1 NADPH oxidase enabling TNFα/IL-1β-induced ROS production and NF-κB activation, and (4) F-actin binding to the C-terminus is required for hypotonic activation.","evidence":"Overexpression with pH manipulation and E224A mutagenesis for antiport; co-IP and mutagenesis of dileucine motif for trafficking; co-IP with Nox1, shRNA, and NF-κB reporter for endosomal ROS; GST pulldown with F-actin and peptide competition with patch-clamp for cytoskeletal interaction","pmids":["17977943","17652080","17673675","17442672"],"confidence":"High","gaps":["Structural basis of Cl⁻/H⁺ coupling unknown","How Nox1-ClC-3 coupling is regulated remains unclear","F-actin interaction domain not structurally characterized"]},{"year":2008,"claim":"ClC-3 was shown to participate in diverse cellular processes beyond ion transport: premitotic cytoplasmic condensation during cell division, CaMKII-dependent glioma invasion, endosomal-dependent exocytosis in chromaffin cells, postsynaptic modulation of NMDA receptor responses, and cardiac VSOAC activity essential for cardioprotection.","evidence":"Patch-clamp at defined cell cycle stages with shRNA; co-IP of ClC-3 with CaMKII in glioma biopsies and invasion assays; Clcn3⁻/⁻ chromaffin cell capacitance measurements; co-IP with NMDA receptors and surface biotinylation in hippocampal neurons with Clcn3⁻/⁻ comparison; cardiac-specific inducible knockout with echocardiography","pmids":["18784301","20139089","18923035","17046694","19615374"],"confidence":"High","gaps":["Molecular basis of ClC-3/NMDA receptor interaction not defined","Whether cardiac hypertrophy is directly due to loss of volume regulation or secondary effects unknown","Mechanism linking endosomal ClC-3 to LDCV exocytosis indirect"]},{"year":2009,"claim":"Two studies defined the biophysical basis and physiological scope of ClC-3 antiport: pH-dependent uncoupling of Cl⁻/H⁺ exchange at low luminal pH was characterized, and ClC-3 on insulin secretory granules was shown essential for granule acidification and priming, with >60% reduction in insulin secretion in Clcn3⁻/⁻ beta cells.","evidence":"Systematic pH manipulation with E224A and cysteine mutagenesis in HEK293 cells; Clcn3⁻/⁻ beta cells with insulin secretion assays, capacitance measurements, and immuno-EM of LDCVs","pmids":["19926787","19808023"],"confidence":"High","gaps":["Physiological relevance of uncoupling at extreme pH not clear","Whether impaired insulin secretion contributes to metabolic phenotype in vivo not tested"]},{"year":2011,"claim":"Presynaptic ClC-3 on GABAergic synaptic vesicles was shown essential for inhibitory neurotransmission by enabling Cl⁻-dependent vesicle acidification and GABA loading, while CaMKII-phosphorylated ClC-3 at postsynaptic sites was found to limit long-term potentiation magnitude.","evidence":"Hippocampal slice electrophysiology and vesicle acidification assays in Clcn3⁻/⁻ mice; LTP recordings with phospho-site decoy peptide","pmids":["21378974","23165767"],"confidence":"High","gaps":["Whether ClC-3 is the sole vesicular Cl⁻/H⁺ exchanger on inhibitory SVs not resolved","Mechanism by which postsynaptic ClC-3 constrains LTP expression unknown"]},{"year":2012,"claim":"ClC-3 deficiency leads to larger synaptic vesicles with increased glutamate content and enhanced excitatory transmission, providing a mechanism for excitotoxic neurodegeneration, while in VSMCs ClC-3 was confirmed as necessary for CaMKII-dependent migration regulated by Ins(3,4,5,6)P4.","evidence":"Patch-clamp with γ-DGG antagonism and EM of SVs in Clcn3⁻/⁻ hippocampal neurons; ClC-3 null VSMCs with CaMKII inhibitor and Ins(3,4,5,6)P4 in transwell migration","pmids":["24904288","23150504"],"confidence":"High","gaps":["Whether altered SV size is a direct consequence of antiport loss or secondary adaptation unknown","How Ins(3,4,5,6)P4 binding inhibits ClC-3 structurally is undefined"]},{"year":2015,"claim":"Characterization of three ClC-3 splice variants revealed isoform-specific targeting motifs directing differential endosomal compartment sorting while preserving identical Cl⁻/H⁺ exchange, explaining how a single gene supports functions in multiple compartments.","evidence":"Splice variant identification in mouse brain, mutagenesis of N-terminal dileucine and IP motifs, co-localization with compartment markers, electrophysiology","pmids":["26342074"],"confidence":"High","gaps":["Relative expression of each isoform across tissues not quantified","Functional consequence of isoform-specific sorting in vivo not tested"]},{"year":2016,"claim":"ROCK2 phosphorylation at T532 was identified as a third kinase regulatory input activating ClC-3 at the plasma membrane downstream of angiotensin II, linking ClC-3 to vascular remodeling.","evidence":"Co-IP, T532D/T532A mutagenesis, ROCK2 siRNA, patch-clamp, transwell migration, ClC-3 null mice cerebrovascular phenotype","pmids":["26562480"],"confidence":"High","gaps":["Whether PKC, CaMKII, and ROCK2 regulate ClC-3 cooperatively or independently at the same channels unknown","Structural basis of T532 regulation not defined"]},{"year":2017,"claim":"ClC-3 was established as the obligate heterodimerization partner directing ClC-4 out of the ER to endosomal compartments, revealing a non-cell-autonomous trafficking function.","evidence":"Heterologous co-expression, Clcn3⁻/⁻ astrocytes showing ClC-4 ER retention, clear native PAGE demonstrating stable ClC-3/ClC-4 heterodimers","pmids":["28972156"],"confidence":"High","gaps":["Whether ClC-3/ClC-4 heterodimers have altered transport properties versus homodimers not tested","Stoichiometry of heterodimer not resolved"]},{"year":2018,"claim":"Detailed gating analysis revealed that coupled Cl⁻/H⁺ exchange depends on interaction between the external gating glutamate E224 and the central tyrosine gate Y572, with low luminal pH inhibiting transport—establishing the molecular basis for self-limiting acidification.","evidence":"Systematic mutagenesis (E224A, Y572S, Y572F, M531A) with gating charge analysis and cytoplasmic alkalization rate measurement","pmids":["29917234"],"confidence":"High","gaps":["No high-resolution structure of ClC-3 available","Conformational dynamics of gate interaction not resolved"]},{"year":2021,"claim":"Human genetic evidence directly linked CLCN3 to neurodevelopmental disease: both loss-of-function and gain-of-function missense variants (p.Ile607Thr, p.Thr570Ile showing increased currents and loss of pH inhibition) cause GDD/ID with brain malformations, demonstrating bidirectional sensitivity to ClC-3 dysfunction.","evidence":"Whole-exome sequencing in affected families, electrophysiological characterization of variants in Xenopus oocytes and mammalian cells, clinical MRI","pmids":["34186028"],"confidence":"High","gaps":["Pathogenic mechanism of gain-of-function variants at the cellular level not defined","Genotype-phenotype correlation across variant spectrum incomplete"]},{"year":null,"claim":"Major unresolved questions include the high-resolution structure of ClC-3, the structural basis of Ins(3,4,5,6)P4 inhibition, how ClC-3 coordinates with V-ATPase stoichiometrically in different vesicle types, and whether gain-of-function and loss-of-function CLCN3 variants cause neurodegeneration through shared or distinct cellular mechanisms.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No cryo-EM or X-ray structure of ClC-3","Ins(3,4,5,6)P4 binding site not mapped","In vivo isoform-specific functions not dissected with conditional knockouts"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,2,3,4,12,20,22,33]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[5,6,21,24]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[5,6,14,19,22,30]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[5,6,30]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[8,19,21,24]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,10,11,13,17]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,2,3,4,10,12,20,22,33]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[11,24,26,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[14,23,31,35]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,13,30,32]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[17,25]}],"complexes":["ClC-3/ClC-4 heterodimer"],"partners":["CLCN4","CAMK2A","ROCK2","EBP50","VDAC1","GRIN1","AP3B1"],"other_free_text":[]},"mechanistic_narrative":"CLCN3 encodes ClC-3, an intracellular Cl⁻/H⁺ antiporter that provides charge compensation for V-ATPase-driven acidification of endosomes, lysosomes, synaptic vesicles, and insulin secretory granules, thereby supporting lysosomal degradation, neurotransmitter loading, and insulin granule priming [PMID:12059962, PMID:21378974, PMID:19808023, PMID:17977943]. ClC-3 splice variants are differentially targeted to late endosomes/lysosomes or recycling endosomes via N-terminal dileucine and isoleucine-proline motifs through clathrin- and AP-3-dependent trafficking, and ClC-3 heterodimerizes with ClC-4 to direct ClC-4 compartmental sorting [PMID:26342074, PMID:17652080, PMID:15073168, PMID:28972156]. At the plasma membrane, CaMKII phosphorylation at S109 and ROCK2 phosphorylation at T532 activate ClC-3-mediated Cl⁻ efflux that drives cell volume regulation, premitotic cytoplasmic condensation, and cell migration, while within signaling endosomes ClC-3 provides charge neutralization for Nox1-dependent ROS production and downstream NF-κB activation [PMID:14754994, PMID:26562480, PMID:18784301, PMID:17673675]. De novo missense and homozygous loss-of-function variants in CLCN3 cause neurodevelopmental disorders with global developmental delay, intellectual disability, and structural brain abnormalities [PMID:34186028]."},"prefetch_data":{"uniprot":{"accession":"P51790","full_name":"H(+)/Cl(-) exchange transporter 3","aliases":["Chloride channel protein 3","ClC-3","Chloride transporter ClC-3"],"length_aa":818,"mass_kda":91.0,"function":"Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons (By similarity). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (PubMed:29845874). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (PubMed:29845874) Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons","subcellular_location":"Golgi apparatus membrane; Cell projection, ruffle membrane","url":"https://www.uniprot.org/uniprotkb/P51790/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLCN3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SCAMP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CLCN3","total_profiled":1310},"omim":[{"mim_id":"619517","title":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES; NEDSBA","url":"https://www.omim.org/entry/619517"},{"mim_id":"619512","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA","url":"https://www.omim.org/entry/619512"},{"mim_id":"612165","title":"RETINITIS PIGMENTOSA 29; RP29","url":"https://www.omim.org/entry/612165"},{"mim_id":"602727","title":"CHLORIDE CHANNEL 7; CLCN7","url":"https://www.omim.org/entry/602727"},{"mim_id":"602024","title":"CHLORIDE CHANNEL, KIDNEY, A; CLCNKA","url":"https://www.omim.org/entry/602024"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CLCN3"},"hgnc":{"alias_symbol":["CLC3","ClC-3"],"prev_symbol":[]},"alphafold":{"accession":"P51790","domains":[{"cath_id":"1.10.3080.10","chopping":"134-365","consensus_level":"medium","plddt":89.2848,"start":134,"end":365},{"cath_id":"1.10.3080.10","chopping":"386-476_485-631","consensus_level":"high","plddt":87.7268,"start":386,"end":631},{"cath_id":"3.10.580.20","chopping":"653-814","consensus_level":"high","plddt":84.0905,"start":653,"end":814}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51790","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51790-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51790-F1-predicted_aligned_error_v6.png","plddt_mean":80.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLCN3","jax_strain_url":"https://www.jax.org/strain/search?query=CLCN3"},"sequence":{"accession":"P51790","fasta_url":"https://rest.uniprot.org/uniprotkb/P51790.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51790/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51790"}},"corpus_meta":[{"pmid":"17673675","id":"PMC_17673675","title":"Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3.","date":"2007","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/17673675","citation_count":173,"is_preprint":false},{"pmid":"9874688","id":"PMC_9874688","title":"A serine residue in ClC-3 links phosphorylation-dephosphorylation to chloride channel regulation by cell volume.","date":"1999","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9874688","citation_count":147,"is_preprint":false},{"pmid":"11274166","id":"PMC_11274166","title":"Regulation of human CLC-3 channels by multifunctional Ca2+/calmodulin-dependent protein kinase.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274166","citation_count":127,"is_preprint":false},{"pmid":"16522634","id":"PMC_16522634","title":"Anion channels, including ClC-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16522634","citation_count":124,"is_preprint":false},{"pmid":"12059962","id":"PMC_12059962","title":"CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis.","date":"2002","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/12059962","citation_count":122,"is_preprint":false},{"pmid":"11997263","id":"PMC_11997263","title":"The ClC-3 chloride channel promotes acidification of lysosomes in CHO-K1 and Huh-7 cells.","date":"2002","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11997263","citation_count":114,"is_preprint":false},{"pmid":"10973952","id":"PMC_10973952","title":"Biophysical properties of ClC-3 differentiate it from swelling-activated chloride channels in Chinese hamster ovary-K1 cells.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10973952","citation_count":109,"is_preprint":false},{"pmid":"20139089","id":"PMC_20139089","title":"Molecular interaction and functional regulation of ClC-3 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20139089","citation_count":109,"is_preprint":false},{"pmid":"10747184","id":"PMC_10747184","title":"The role of ClC-3 in volume-activated chloride currents and volume regulation in bovine epithelial cells demonstrated by antisense inhibition.","date":"2000","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10747184","citation_count":98,"is_preprint":false},{"pmid":"15073168","id":"PMC_15073168","title":"AP-3-dependent mechanisms control the targeting of a chloride channel (ClC-3) in neuronal and non-neuronal cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15073168","citation_count":98,"is_preprint":false},{"pmid":"18784301","id":"PMC_18784301","title":"ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18784301","citation_count":97,"is_preprint":false},{"pmid":"12183454","id":"PMC_12183454","title":"ClC-3 is a fundamental molecular component of volume-sensitive outwardly rectifying Cl- channels and volume regulation in HeLa cells and Xenopus laevis oocytes.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12183454","citation_count":95,"is_preprint":false},{"pmid":"12433844","id":"PMC_12433844","title":"Deficiency in ClC-3 chloride channels prevents rat aortic smooth muscle cell proliferation.","date":"2002","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12433844","citation_count":93,"is_preprint":false},{"pmid":"12470859","id":"PMC_12470859","title":"Altered GABAergic function accompanies hippocampal degeneration in mice lacking ClC-3 voltage-gated chloride channels.","date":"2002","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12470859","citation_count":90,"is_preprint":false},{"pmid":"16697056","id":"PMC_16697056","title":"The ClC-3 Cl- channel in cell volume regulation, proliferation and apoptosis in vascular smooth muscle cells.","date":"2006","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16697056","citation_count":89,"is_preprint":false},{"pmid":"11278960","id":"PMC_11278960","title":"Human ClC-3 is not the swelling-activated chloride channel involved in cell volume regulation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278960","citation_count":85,"is_preprint":false},{"pmid":"15596438","id":"PMC_15596438","title":"Regulation of intracellular Cl- concentration through volume-regulated ClC-3 chloride channels in A10 vascular smooth muscle cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15596438","citation_count":84,"is_preprint":false},{"pmid":"12433961","id":"PMC_12433961","title":"Secretion and cell volume regulation by salivary acinar cells from mice lacking expression of the Clcn3 Cl- channel gene.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12433961","citation_count":83,"is_preprint":false},{"pmid":"23345219","id":"PMC_23345219","title":"Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23345219","citation_count":81,"is_preprint":false},{"pmid":"17977943","id":"PMC_17977943","title":"Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17977943","citation_count":75,"is_preprint":false},{"pmid":"21115901","id":"PMC_21115901","title":"Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.","date":"2010","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21115901","citation_count":75,"is_preprint":false},{"pmid":"23509947","id":"PMC_23509947","title":"ClC-3 is an intracellular chloride/proton exchanger with large voltage-dependent nonlinear capacitance.","date":"2013","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23509947","citation_count":75,"is_preprint":false},{"pmid":"7665160","id":"PMC_7665160","title":"Characterization of a human and murine gene (CLCN3) sharing similarities to voltage-gated chloride channels and to a yeast integral membrane protein.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7665160","citation_count":71,"is_preprint":false},{"pmid":"18359479","id":"PMC_18359479","title":"Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells.","date":"2008","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18359479","citation_count":69,"is_preprint":false},{"pmid":"11230516","id":"PMC_11230516","title":"Functional inhibition of native volume-sensitive outwardly rectifying anion channels in muscle cells and Xenopus oocytes by anti-ClC-3 antibody.","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11230516","citation_count":69,"is_preprint":false},{"pmid":"11967229","id":"PMC_11967229","title":"ClC-3B, a novel ClC-3 splicing variant that interacts with EBP50 and facilitates expression of CFTR-regulated ORCC.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11967229","citation_count":69,"is_preprint":false},{"pmid":"12816749","id":"PMC_12816749","title":"Functional effects of novel anti-ClC-3 antibodies on native volume-sensitive osmolyte and anion channels in cardiac and smooth muscle cells.","date":"2003","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12816749","citation_count":68,"is_preprint":false},{"pmid":"10915634","id":"PMC_10915634","title":"Expression and canalicular localization of two isoforms of the ClC-3 chloride channel from rat hepatocytes.","date":"2000","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10915634","citation_count":67,"is_preprint":false},{"pmid":"8661780","id":"PMC_8661780","title":"Association of ClC-3 channel with Cl- transport by human nonpigmented ciliary epithelial cells.","date":"1996","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/8661780","citation_count":65,"is_preprint":false},{"pmid":"17046694","id":"PMC_17046694","title":"CLC-3 channels modulate excitatory synaptic transmission in hippocampal neurons.","date":"2006","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17046694","citation_count":65,"is_preprint":false},{"pmid":"15256454","id":"PMC_15256454","title":"Bcl-2-dependent modulation of swelling-activated Cl- current and ClC-3 expression in human prostate cancer epithelial cells.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15256454","citation_count":65,"is_preprint":false},{"pmid":"9449697","id":"PMC_9449697","title":"The swelling-activated chloride channel ClC-2, the chloride channel ClC-3, and ClC-5, a chloride channel mutated in kidney stone disease, are expressed in distinct subpopulations of renal epithelial cells.","date":"1998","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9449697","citation_count":65,"is_preprint":false},{"pmid":"15723096","id":"PMC_15723096","title":"ClC-3 chloride channel is upregulated by hypertrophy and inflammation in rat and canine pulmonary artery.","date":"2005","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15723096","citation_count":64,"is_preprint":false},{"pmid":"18823498","id":"PMC_18823498","title":"Silence of ClC-3 chloride channel inhibits cell proliferation and the cell cycle via G/S phase arrest in rat basilar arterial smooth muscle cells.","date":"2008","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/18823498","citation_count":64,"is_preprint":false},{"pmid":"15319524","id":"PMC_15319524","title":"ClC-3-independent, PKC-dependent activity of volume-sensitive Cl channel in mouse ventricular cardiomyocytes.","date":"2004","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15319524","citation_count":60,"is_preprint":false},{"pmid":"20479003","id":"PMC_20479003","title":"Activation of swelling-activated chloride current by tumor necrosis factor-alpha requires ClC-3-dependent endosomal reactive oxygen production.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20479003","citation_count":58,"is_preprint":false},{"pmid":"14754994","id":"PMC_14754994","title":"Identification of an N-terminal amino acid of the CLC-3 chloride channel critical in phosphorylation-dependent activation of a CaMKII-activated chloride current.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14754994","citation_count":58,"is_preprint":false},{"pmid":"21602838","id":"PMC_21602838","title":"The ClC-3 chloride channels in cardiovascular disease.","date":"2011","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/21602838","citation_count":57,"is_preprint":false},{"pmid":"18923035","id":"PMC_18923035","title":"Role of the vesicular chloride transporter ClC-3 in neuroendocrine tissue.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18923035","citation_count":56,"is_preprint":false},{"pmid":"21378974","id":"PMC_21378974","title":"Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus.","date":"2011","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21378974","citation_count":55,"is_preprint":false},{"pmid":"12842831","id":"PMC_12842831","title":"Fundamental role of ClC-3 in volume-sensitive Cl- channel function and cell volume regulation in AGS cells.","date":"2003","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12842831","citation_count":53,"is_preprint":false},{"pmid":"26342074","id":"PMC_26342074","title":"Neuronal ClC-3 Splice Variants Differ in Subcellular Localizations, but Mediate Identical Transport Functions.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26342074","citation_count":52,"is_preprint":false},{"pmid":"18077605","id":"PMC_18077605","title":"ClC-3 is required for LPA-activated Cl- current activity and fibroblast-to-myofibroblast differentiation.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18077605","citation_count":51,"is_preprint":false},{"pmid":"19926787","id":"PMC_19926787","title":"The ClC-3 Cl-/H+ antiporter becomes uncoupled at low extracellular pH.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19926787","citation_count":51,"is_preprint":false},{"pmid":"25421907","id":"PMC_25421907","title":"CLC-3 channels in cancer (review).","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25421907","citation_count":50,"is_preprint":false},{"pmid":"23799775","id":"PMC_23799775","title":"Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23799775","citation_count":50,"is_preprint":false},{"pmid":"11045957","id":"PMC_11045957","title":"Molecular distribution of volume-regulated chloride channels (ClC-2 and ClC-3) in cardiac tissues.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11045957","citation_count":49,"is_preprint":false},{"pmid":"17363491","id":"PMC_17363491","title":"ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment.","date":"2007","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17363491","citation_count":47,"is_preprint":false},{"pmid":"24440986","id":"PMC_24440986","title":"ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice.","date":"2014","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/24440986","citation_count":46,"is_preprint":false},{"pmid":"19808023","id":"PMC_19808023","title":"Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19808023","citation_count":45,"is_preprint":false},{"pmid":"17652080","id":"PMC_17652080","title":"The ClC-3 chloride transport protein traffics through the plasma membrane via interaction of an N-terminal dileucine cluster with clathrin.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17652080","citation_count":44,"is_preprint":false},{"pmid":"18840613","id":"PMC_18840613","title":"ClC-3 and IClswell are required for normal neutrophil chemotaxis and shape change.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18840613","citation_count":44,"is_preprint":false},{"pmid":"17908687","id":"PMC_17908687","title":"Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17908687","citation_count":42,"is_preprint":false},{"pmid":"16520896","id":"PMC_16520896","title":"ClC-3 chloride channel prevents apoptosis induced by thapsigargin in PC12 cells.","date":"2006","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/16520896","citation_count":41,"is_preprint":false},{"pmid":"24743031","id":"PMC_24743031","title":"The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3.","date":"2014","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/24743031","citation_count":38,"is_preprint":false},{"pmid":"18234851","id":"PMC_18234851","title":"Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts.","date":"2008","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18234851","citation_count":37,"is_preprint":false},{"pmid":"21373935","id":"PMC_21373935","title":"ClC-3 chloride channel prevents apoptosis induced by hydrogen peroxide in basilar artery smooth muscle cells through mitochondria dependent pathway.","date":"2011","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/21373935","citation_count":37,"is_preprint":false},{"pmid":"20539936","id":"PMC_20539936","title":"ClC-3 chloride channels are essential for cell proliferation and cell cycle progression in nasopharyngeal carcinoma cells.","date":"2010","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/20539936","citation_count":37,"is_preprint":false},{"pmid":"34186028","id":"PMC_34186028","title":"Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders.","date":"2021","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34186028","citation_count":36,"is_preprint":false},{"pmid":"19615374","id":"PMC_19615374","title":"Cardiac-specific, inducible ClC-3 gene deletion eliminates native volume-sensitive chloride channels and produces myocardial hypertrophy in adult mice.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19615374","citation_count":35,"is_preprint":false},{"pmid":"27451945","id":"PMC_27451945","title":"ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27451945","citation_count":35,"is_preprint":false},{"pmid":"23708799","id":"PMC_23708799","title":"Acid-sensitive outwardly rectifying (ASOR) anion channels in human epithelial cells are highly sensitive to temperature and independent of ClC-3.","date":"2013","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23708799","citation_count":34,"is_preprint":false},{"pmid":"24904288","id":"PMC_24904288","title":"Involvement of ClC-3 chloride/proton exchangers in controlling glutamatergic synaptic strength in cultured hippocampal neurons.","date":"2014","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24904288","citation_count":32,"is_preprint":false},{"pmid":"24026363","id":"PMC_24026363","title":"The ClC-3 chloride channel associated with microtubules is a target of paclitaxel in its induced-apoptosis.","date":"2013","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24026363","citation_count":31,"is_preprint":false},{"pmid":"15674438","id":"PMC_15674438","title":"Hyposmotic activation of ICl,swell in rabbit nonpigmented ciliary epithelial cells involves increased ClC-3 trafficking to the plasma membrane.","date":"2004","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/15674438","citation_count":31,"is_preprint":false},{"pmid":"16037691","id":"PMC_16037691","title":"ClC-3-independent sensitivity of apoptosis to Cl- channel blockers in mouse cardiomyocytes.","date":"2005","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16037691","citation_count":31,"is_preprint":false},{"pmid":"27363391","id":"PMC_27363391","title":"Abrogating ClC-3 Inhibits LPS-induced Inflammation via Blocking the TLR4/NF-κB Pathway.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27363391","citation_count":29,"is_preprint":false},{"pmid":"22496242","id":"PMC_22496242","title":"ClC-3 is a candidate of the channel proteins mediating acid-activated chloride currents in nasopharyngeal carcinoma cells.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22496242","citation_count":29,"is_preprint":false},{"pmid":"23873092","id":"PMC_23873092","title":"ClC-3 deficiency prevents apoptosis induced by angiotensin II in endothelial progenitor cells via inhibition of NADPH oxidase.","date":"2013","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/23873092","citation_count":29,"is_preprint":false},{"pmid":"22371056","id":"PMC_22371056","title":"Cell cycle-dependent subcellular distribution of ClC-3 in HeLa cells.","date":"2012","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22371056","citation_count":28,"is_preprint":false},{"pmid":"11511107","id":"PMC_11511107","title":"Tissue-specific N-glycosylation of the ClC-3 chloride channel.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11511107","citation_count":28,"is_preprint":false},{"pmid":"22049206","id":"PMC_22049206","title":"Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding.","date":"2011","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22049206","citation_count":28,"is_preprint":false},{"pmid":"20506205","id":"PMC_20506205","title":"Chloride channel ClC-3 promotion of osteogenic differentiation through Runx2.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20506205","citation_count":27,"is_preprint":false},{"pmid":"18951024","id":"PMC_18951024","title":"An expanded biological repertoire for Ins(3,4,5,6)P4 through its modulation of ClC-3 function.","date":"2008","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/18951024","citation_count":27,"is_preprint":false},{"pmid":"20154183","id":"PMC_20154183","title":"Chloride channel ClC-3 in gills of the euryhaline teleost, Tetraodon nigroviridis: expression, localization and the possible role of chloride absorption.","date":"2010","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20154183","citation_count":27,"is_preprint":false},{"pmid":"21091354","id":"PMC_21091354","title":"Ion-deficient environment induces the expression of basolateral chloride channel, ClC-3-like protein, in gill mitochondrion-rich cells for chloride uptake of the tilapia Oreochromis mossambicus.","date":"2011","source":"Physiological and biochemical zoology : PBZ","url":"https://pubmed.ncbi.nlm.nih.gov/21091354","citation_count":27,"is_preprint":false},{"pmid":"28969029","id":"PMC_28969029","title":"Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-κB pathway.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28969029","citation_count":26,"is_preprint":false},{"pmid":"15728552","id":"PMC_15728552","title":"Inhibition of swelling-activated Cl- currents by functional anti-ClC-3 antibody in native bovine non-pigmented ciliary epithelial cells.","date":"2005","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15728552","citation_count":25,"is_preprint":false},{"pmid":"28972156","id":"PMC_28972156","title":"Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28972156","citation_count":24,"is_preprint":false},{"pmid":"29917234","id":"PMC_29917234","title":"Modulation of ClC-3 gating and proton/anion exchange by internal and external protons and the anion selectivity filter.","date":"2018","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29917234","citation_count":24,"is_preprint":false},{"pmid":"28419445","id":"PMC_28419445","title":"Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28419445","citation_count":24,"is_preprint":false},{"pmid":"36439880","id":"PMC_36439880","title":"HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36439880","citation_count":23,"is_preprint":false},{"pmid":"29949674","id":"PMC_29949674","title":"Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells.","date":"2018","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/29949674","citation_count":23,"is_preprint":false},{"pmid":"31606620","id":"PMC_31606620","title":"Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31606620","citation_count":23,"is_preprint":false},{"pmid":"10446329","id":"PMC_10446329","title":"Single-cell RT-PCR demonstrates expression of voltage-dependent chloride channels (ClC-1, ClC-2 and ClC-3) in outer hair cells of rat cochlea.","date":"1999","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10446329","citation_count":23,"is_preprint":false},{"pmid":"21792908","id":"PMC_21792908","title":"ClC-3 is a main component of background chloride channels activated under isotonic conditions by autocrine ATP in nasopharyngeal carcinoma cells.","date":"2011","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21792908","citation_count":23,"is_preprint":false},{"pmid":"24284495","id":"PMC_24284495","title":"Swelling-activated Cl- currents and intracellular CLC-3 are involved in proliferation of human pulmonary artery smooth muscle cells.","date":"2014","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/24284495","citation_count":22,"is_preprint":false},{"pmid":"16441975","id":"PMC_16441975","title":"Single-channel properties of volume-sensitive Cl- channel in ClC-3-deficient cardiomyocytes.","date":"2006","source":"The Japanese journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16441975","citation_count":22,"is_preprint":false},{"pmid":"15127135","id":"PMC_15127135","title":"ClC-3 expression in the cell cycle of nasopharyngeal carcinoma cells.","date":"2004","source":"Sheng li xue bao : [Acta physiologica Sinica]","url":"https://pubmed.ncbi.nlm.nih.gov/15127135","citation_count":22,"is_preprint":false},{"pmid":"25973047","id":"PMC_25973047","title":"ClC-3 chloride channel modulates the proliferation and migration of osteosarcoma cells via AKT/GSK3β signaling pathway.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25973047","citation_count":21,"is_preprint":false},{"pmid":"17442672","id":"PMC_17442672","title":"Hypotonic activation of short ClC3 isoform is modulated by direct interaction between its cytosolic C-terminal tail and subcortical actin filaments.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17442672","citation_count":20,"is_preprint":false},{"pmid":"29977005","id":"PMC_29977005","title":"ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation.","date":"2018","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/29977005","citation_count":20,"is_preprint":false},{"pmid":"25218423","id":"PMC_25218423","title":"ClC-3 deficiency protects preadipocytes against apoptosis induced by palmitate in vitro and in type 2 diabetes mice.","date":"2014","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/25218423","citation_count":19,"is_preprint":false},{"pmid":"23150504","id":"PMC_23150504","title":"Functional regulation of ClC-3 in the migration of vascular smooth muscle cells.","date":"2012","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/23150504","citation_count":19,"is_preprint":false},{"pmid":"23786998","id":"PMC_23786998","title":"Deficiency of volume-regulated ClC-3 chloride channel attenuates cerebrovascular remodelling in DOCA-salt hypertension.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23786998","citation_count":19,"is_preprint":false},{"pmid":"26562480","id":"PMC_26562480","title":"Threonine532 phosphorylation in ClC-3 channels is required for angiotensin II-induced Cl(-) current and migration in cultured vascular smooth muscle cells.","date":"2016","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26562480","citation_count":19,"is_preprint":false},{"pmid":"26925421","id":"PMC_26925421","title":"ClC-3 Expression and Its Association with Hyperglycemia Induced HT22 Hippocampal Neuronal Cell Apoptosis.","date":"2016","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/26925421","citation_count":19,"is_preprint":false},{"pmid":"24603049","id":"PMC_24603049","title":"A newly cloned ClC-3 isoform, ClC-3d, as well as ClC-3a mediates Cd-sensitive outwardly rectifying anion currents.","date":"2014","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24603049","citation_count":19,"is_preprint":false},{"pmid":"23165767","id":"PMC_23165767","title":"CLC-3 chloride channels moderate long-term potentiation at Schaffer collateral-CA1 synapses.","date":"2012","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23165767","citation_count":19,"is_preprint":false},{"pmid":"23292336","id":"PMC_23292336","title":"The ClC-3 chloride channel and osmoregulation in the European sea bass, Dicentrarchus labrax.","date":"2013","source":"Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23292336","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52862,"output_tokens":10925,"usd":0.16123},"stage2":{"model":"claude-opus-4-6","input_tokens":14821,"output_tokens":4706,"usd":0.287633},"total_usd":0.448863,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"CLCN3 encodes a 760-amino-acid protein belonging to the voltage-gated chloride channel (ClC) family, with high sequence similarity to GEF1 (a yeast integral membrane protein involved in respiration and iron-limited growth), indicating conserved fundamental function; the gene is expressed primarily in neuroectoderm-derived tissues, with high hippocampal, olfactory cortex, and olfactory bulb expression.\",\n      \"method\": \"Molecular cloning, sequence analysis, Northern blot/in situ hybridization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — original cloning paper with sequence/structural characterization; single lab, foundational characterization\",\n      \"pmids\": [\"7665160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ClC-3 volume-regulated chloride channel activity is controlled by phosphorylation/dephosphorylation: PKC activation closes the channel, PKC inhibition opens it, and serine51 in the intracellular N-terminus (within a consensus PKC phosphorylation site) is the critical volume sensor residue.\",\n      \"method\": \"Site-directed mutagenesis, patch-clamp electrophysiology in cardiac cells and NIH/3T3 cells overexpressing ClC-3\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with patch-clamp functional validation; replicated in native and recombinant systems\",\n      \"pmids\": [\"9874688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"When expressed in CHO-K1 cells, ClC-3 produces Cl->I- selective, extremely outward-rectifying currents insensitive to NPPB, DIDS, and phorbol esters and not activated by osmotic swelling—properties identical to ClC-5 and distinct from endogenous swelling-activated channels, demonstrating ClC-3 is not the swelling-activated channel under all conditions.\",\n      \"method\": \"Transient transfection of rat ClC-3 into CHO-K1 cells, whole-cell patch-clamp electrophysiology, pharmacological profiling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — rigorous biophysical characterization with multiple pharmacological controls in a defined expression system\",\n      \"pmids\": [\"10973952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CaMKII phosphorylation regulates the plasma membrane expression and activity of hCLC-3: intracellular infusion of autonomously active CaMKII increased ClC-3 currents ~22-fold in stably transfected tsA cells, and mutation of glycine 280 to glutamic acid in the pore region changed anion selectivity from I->Cl- to Cl->I-.\",\n      \"method\": \"Stable transfection of hCLC-3 in tsA cells, whole-cell patch-clamp with CaMKII infusion, AIP inhibitor, pore-region mutagenesis, surface biotinylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution with kinase infusion, specific inhibitor, and mutagenesis\",\n      \"pmids\": [\"11274166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Intracellular dialysis of anti-ClC-3 antibody completely abolished expressed ClC-3 currents and native volume-sensitive outwardly rectifying anion channel (VSOAC) currents in guinea-pig cardiac cells, canine pulmonary arterial smooth muscle cells, and Xenopus oocytes, establishing ClC-3 as a major molecular entity of VSOACs in these cell types.\",\n      \"method\": \"Intracellular dialysis of polyclonal anti-ClC-3 antibody during whole-cell patch-clamp recording; antigen preabsorption controls\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — functional antibody inhibition with rigorous antigen-preabsorption specificity controls, replicated across multiple cell types\",\n      \"pmids\": [\"11230516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Heterologous ClC-3 expression in CHO-K1 and Huh-7 cells promotes lysosomal acidification: overexpression creates large acidic vesicles co-labeled with LAMP-1, LAMP-2, and cathepsin D; vesicle formation requires both V-ATPase proton pumping and ClC-3 Cl- channel activity (blocked by E224A mutant), consistent with ClC-3 providing charge neutralization for lysosomal acidification.\",\n      \"method\": \"Heterologous overexpression, bafilomycin treatment, E224A mutagenesis, organelle pH measurement, co-localization with lysosomal markers\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and multiple orthogonal methods confirming lysosomal identity and functional dependence\",\n      \"pmids\": [\"11997263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CLC-3-deficient (Clcn3-/-) mice exhibit elevated endosomal pH, progressive neurodegeneration of hippocampus and retina, and lysosomal accumulation of mitochondrial F1F0 ATPase subunit c, phenocopying neuronal ceroid lipofuscinosis, establishing ClC-3 as required for endosomal acidification and lysosomal protein degradation.\",\n      \"method\": \"Targeted gene disruption (Clcn3-/- mice), endosomal pH measurement, immunohistochemistry, Western blot, histological analysis\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with multiple orthogonal functional readouts; replicated by independent lab\",\n      \"pmids\": [\"12059962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ClC-3 antisense oligonucleotides significantly reduce volume-sensitive osmolyte and anion channel (VSOAC) density and impair regulatory volume decrease in HeLa cells and Xenopus oocytes, supporting ClC-3 as a fundamental molecular component of VSOACs.\",\n      \"method\": \"ClC-3 antisense transfection/injection, semi-quantitative and real-time PCR, immunoblot, hypotonic whole-cell recording, cell volume measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antisense knockdown with multiple orthogonal endpoints in two cell systems; single lab\",\n      \"pmids\": [\"12183454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ClC-3 is sorted to synaptic vesicles via an AP-3-dependent trafficking pathway; ClC-3 levels in synaptic vesicles and hippocampal mossy fiber terminals are reduced in AP-3-deficient mocha mice; in PC-12 cells ClC-3 trafficking to synaptic-like microvesicles is brefeldin A-sensitive; increased ClC-3 expression enhances vesicular zinc transport in concert with ZnT3, with which it co-segregates.\",\n      \"method\": \"AP-3-deficient mocha mouse model, subcellular fractionation, immunohistochemistry, brefeldin A treatment, ZnT3 co-fractionation and functional zinc transport assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in genetic model plus functional vesicular transport readout\",\n      \"pmids\": [\"15073168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ClC-3B, a novel C-terminal splice variant of ClC-3, interacts with the PDZ domain of EBP50 via a C-terminal PDZ-binding motif; co-transfection of ClC-3B with EBP50 redistributes ClC-3B to the leading edge of membrane ruffles and produces a remarkable increase in ORCC currents that can be activated by CFTR via PKA-dependent pathway.\",\n      \"method\": \"Cloning, in vitro and in vivo binding assays (GST pulldown, co-IP), immunofluorescence, whole-cell patch-clamp\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — biochemical interaction assays combined with electrophysiological functional readout and localization\",\n      \"pmids\": [\"11967229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CaMKII phosphorylates the N-terminus of CLC-3 in vitro, and serine 109 (S109) in the N-terminal CaMKII consensus sequence is critical for CaMKII-dependent Cl- conductance at the plasma membrane; S109A mutation abolishes the CaMKII-activated current.\",\n      \"method\": \"In vitro kinase phosphorylation assay, site-directed mutagenesis (S109A), whole-cell patch-clamp with CaMKII infusion in smooth muscle cells and HT29 cells, CLC-3-/- cells as negative control\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus mutagenesis with electrophysiological validation; genetic null control\",\n      \"pmids\": [\"14754994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Neuronal excitability is modulated by CLC-3 at postsynaptic sites: CaMKII-activated CLC-3 Cl- conductance enhances NMDA receptor-mediated miniature EPSPs in a Cl--dependent fashion; CLC-3 co-immunoprecipitates with NMDA receptors and is localized at postsynaptic sites by electron microscopy and surface biotinylation; this conductance is absent in clc-3-/- mice.\",\n      \"method\": \"Patch-clamp electrophysiology in hippocampal neurons, surface biotinylation, immunohistochemistry, electron microscopy, co-immunoprecipitation, clc-3-/- knockout comparison\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple orthogonal methods including genetic null, co-IP, EM, and electrophysiology\",\n      \"pmids\": [\"17046694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ClC-3 overexpression in HEK293T cells induces pH-dependent outwardly rectifying currents with reversal potential shifts of ~10 mV/decade pH change and ~48 mV/decade Cl- change (non-Nernstian), indicating coupled Cl-/H+ antiport; E224A mutation removes pH sensitivity and restores Nernstian Cl- dependence, identifying E224 as the extracellular glutamate gate governing coupling.\",\n      \"method\": \"Heterologous overexpression in HEK293T, whole-cell patch-clamp, extracellular pH manipulation, E224A mutagenesis, reversal potential analysis\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of gating residue with quantitative biophysical characterization establishing Cl-/H+ antiport mechanism\",\n      \"pmids\": [\"17977943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ClC-3 is primarily an intracellular transport protein that traffics through the plasma membrane via clathrin-mediated endocytosis; the N-terminal dileucine acidic cluster (amino acids 13-19) interacts directly with clathrin (demonstrated by co-IP and GST pulldown), and alanine replacement of this motif reduces endocytosis, increases plasma membrane expression, and abolishes clathrin binding.\",\n      \"method\": \"Pulse-labeling, surface biotinylation, immunofluorescence, co-immunoprecipitation, GST pulldown, alanine-substitution mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — biochemical interaction assays with mutagenesis and trafficking quantification; multiple orthogonal methods\",\n      \"pmids\": [\"17652080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In vascular smooth muscle cells, Nox1 (NADPH oxidase subunit) and p22phox co-immunoprecipitate with early endosomal markers; ClC-3 co-localizes with Nox1 in early endosomes and is required for cytokine (TNF-α, IL-1β)-induced intraendosomal ROS production and subsequent NF-κB activation, functioning as a charge compensator for Nox1-generated electron flow across the endosomal membrane.\",\n      \"method\": \"Co-immunoprecipitation, co-localization by confocal microscopy, ROS measurement, NF-κB reporter assay, shRNA knockdown of ClC-3\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional ROS and NF-κB readouts, multiple orthogonal approaches\",\n      \"pmids\": [\"17673675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hypotonic activation of the short ClC-3 isoform (sClC-3) requires direct interaction between its cytosolic C-terminal tail and filamentous (F-) actin, but not G-actin; the F-actin binding region maps to amino acids 690-760, and peptides disrupting this interaction reduce VSOAC current density by ~40-60% upon intracellular dialysis.\",\n      \"method\": \"GST pulldown/co-sedimentation assays with F-actin, truncation mapping, synthetic peptide competition, intracellular dialysis with peptides + patch-clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted binding with domain mapping plus functional electrophysiological validation via peptide competition\",\n      \"pmids\": [\"17442672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ClC-3 is required for CaMKII-dependent Cl- currents in glioma cells; CaMKII co-localizes and co-immunoprecipitates with ClC-3 in glioma cells and in GBM patient biopsies; shRNA knockdown of ClC-3 eliminates CaMKII-dependent currents, and inhibition of CaMKII reduces glioma invasion to the same extent as direct ClC-3 inhibition.\",\n      \"method\": \"Co-immunoprecipitation, whole-cell patch-clamp with CaMKII infusion, shRNA knockdown, AIP inhibitor, invasion assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional KD and invasion readouts; replicated in patient tissue\",\n      \"pmids\": [\"20139089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ClC-3 channels are required for premitotic cytoplasmic condensation (PMC) during cell division: patch-clamp shows upregulation of Cl- currents at M phase; ClC-3 is present on the plasma membrane and at the mitotic spindle (co-localization and co-IP); shRNA knockdown of ClC-3 reduces M-phase Cl- currents, slows PMC rate, and impairs DNA condensation.\",\n      \"method\": \"Patch-clamp electrophysiology at defined cell cycle stages, co-immunoprecipitation, immunofluorescence co-localization, shRNA knockdown\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches with specific cell-cycle-dependent functional readouts and genetic KD\",\n      \"pmids\": [\"18784301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ins(3,4,5,6)P4 inhibits ClC-3-mediated Cl- conductance at the plasma membrane and raises intra-endosomal pH (inhibits ClC-3 Cl-/H+ exchange in endosomes), and also inhibits endogenous ClC-3 conductance in postsynaptic membranes of neonatal hippocampal neurons, identifying Ins(3,4,5,6)P4 as a physiological regulator of ClC-3.\",\n      \"method\": \"Heterologous expression in HEK293 cells, whole-cell patch-clamp, fluorescence ratio imaging of endosomal pH with FITC-transferrin, cell-permeant Ins(3,4,5,6)P4 analog\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct functional assays in plasma membrane and endosomal contexts with specific membrane-permeant agonist, replicated across compartments\",\n      \"pmids\": [\"18951024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ClC-3 localizes to endosomes and synaptic-like microvesicles (not large dense-core vesicles) in adrenal chromaffin and pancreatic beta cells; Clcn3-/- chromaffin cells show decreased exocytosis of large dense-core vesicles (capacitance measurements and amperometry), indicating an indirect role of ClC-3 in LDCV exocytosis through endosomal trafficking steps.\",\n      \"method\": \"Immunohistochemistry, subcellular fractionation, capacitance measurements, carbon-fiber amperometry, Clcn3-/- knockout mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with direct exocytosis measurement and precise subcellular fractionation\",\n      \"pmids\": [\"18923035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ClC-3 Cl-/H+ exchange becomes uncoupled at low extracellular pH: between pH 8.2-6.2 protons shift the reversal potential, but below pH 6.2 Cl- transport and H+ transport uncouple; at pH 4.0 ClC-3 behaves as a purely anion-selective channel; extracellular cysteine residues (103-130 region) mediate MTSES-sensitivity; an E224A mutant lacks pH sensitivity and restores Nernstian Cl- dependence.\",\n      \"method\": \"Adenoviral ClC-3 expression in HEK293, whole-cell patch-clamp, pH and Cl- concentration manipulation, MTSES modification, mutagenesis (E224A, C103_P130del), shRNA knockdown of endogenous ClC-3\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis and chemical modification with quantitative biophysical analysis of coupling mechanism\",\n      \"pmids\": [\"19926787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ClC-3 is expressed on insulin secretory granules in pancreatic beta cells and is required for granule priming: Clcn3-/- beta cells show >60% reduction in glucose- and sulfonylurea-evoked insulin secretion, ~80% reduction in depolarization-evoked exocytosis (capacitance measurements), and 44% reduction in proton transport across granule membranes; ClC-3 on LDCVs was confirmed by immunoblot, immunostaining, and immunoelectron microscopy.\",\n      \"method\": \"Clcn3-/- knockout mice, insulin secretion assay, single-cell capacitance measurements, vesicle proton transport assay, immunoblot/immunostaining/immuno-EM of purified LDCVs\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — genetic knockout with multiple quantitative functional assays and direct subcellular localization to LDCVs by immuno-EM\",\n      \"pmids\": [\"19808023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ClC-3 is a Cl-/H+ antiporter with biophysical properties similar to ClC-4 and ClC-5; an N-terminal retention signal keeps endogenous ClC-3 off the plasma membrane; N-terminal mutation (ClC-313-19A) allows surface expression and reveals outwardly rectifying coupled Cl-/H+ exchange; ClC-3 also exhibits large voltage-dependent nonlinear capacitance exceeding that of ClC-4 and ClC-5, and mutations of the proton glutamate decrease transport but increase capacitance.\",\n      \"method\": \"Electrophysiology combined with fluorescence pH measurements, N-terminal mutagenesis, proton glutamate mutagenesis, mathematical modeling\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and direct fluorescence pH transport assays; mathematical modeling of mechanism\",\n      \"pmids\": [\"23509947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TNF-α activates swelling-activated Cl- current (ICl,swell) in vascular smooth muscle cells via ClC-3-dependent endosomal H2O2 production: ICl,swell was absent in ClC-3 null cells, was activated by H2O2, was blocked by catalase, and was abolished by dominant-negative Rab5 or Rab11 (disrupting endosome trafficking), establishing a mechanistic link between ClC-3 endosomal ROS generation and ICl,swell activation.\",\n      \"method\": \"Perforated patch-clamp, ClC-3 null mouse VSMCs, catalase treatment, dominant-negative Rab5/Rab11 expression, H2O2 challenge\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — genetic null + pharmacological + dominant-negative trafficking disruption with defined electrophysiological readouts\",\n      \"pmids\": [\"20479003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Presynaptic CLC-3 on GABAergic synaptic vesicles is required for normal inhibitory transmission in hippocampus: Clcn3-/- slices show decreased amplitude and frequency of miniature IPSCs; CLC-3 co-localizes with VGAT in CA1; Cl--dependent acidification of inhibitory synaptic vesicles is markedly reduced in Clcn3-/- neurons, indicating CLC-3 enables neurotransmitter loading by supporting vesicle acidification.\",\n      \"method\": \"Hippocampal slice electrophysiology, immunofluorescence co-localization with VGAT, vesicle acidification assay with Cl- dependence, Clcn3-/- knockout\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with electrophysiological and direct vesicle acidification assays; high-impact journal\",\n      \"pmids\": [\"21378974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CaMKII-dependent kinase activation of ClC-3 drives cytoplasmic condensation (PMC) during mitotic cell rounding in human glioma cells; time-lapse microscopy shows PMC is reduced by ClC-3 shRNA knockdown or KN-93 (CaMKII inhibitor); CaMKII activates ClC-3 Cl- currents in dividing cells, leading to Cl- efflux-driven volume decrease.\",\n      \"method\": \"Time-lapse microscopy, patch-clamp electrophysiology at mitosis, shRNA knockdown of ClC-3, CaMKII inhibitor KN-93\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live imaging of cell volume with genetic and pharmacological perturbation and electrophysiological confirmation\",\n      \"pmids\": [\"22049206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CLC-3 co-localizes with NMDA receptors at postsynaptic sites and its phosphorylation by CaMKII is required for its regulatory function in long-term potentiation (LTP): CLC-3 knockout increases LTP by ~40% above wild type; a decoy peptide of the CaMKII phosphorylation site on CLC-3 mimics the knockout effect on LTP, demonstrating that phosphorylated CLC-3 limits synaptic potentiation.\",\n      \"method\": \"Hippocampal slice LTP recordings, CLC-3 knockout mice, decoy phosphorylation peptide intracellular infusion\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout combined with phospho-site decoy peptide in defined electrophysiological assay\",\n      \"pmids\": [\"23165767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ClC-3 deficiency results in larger synaptic vesicles and increased amplitude/frequency of miniature EPSCs and action-potential-evoked EPSCs in hippocampal neurons; low-affinity AMPA receptor antagonist γ-DGG reduces quantal size more in WT than Clcn3-/- neurons, indicating ClC-3 controls glutamate loading into synaptic vesicles and affects release probability, with excessive glutamate release as a likely basis of neurodegeneration.\",\n      \"method\": \"Whole-cell patch-clamp in cultured hippocampal neurons from Clcn3-/- mice, γ-DGG and NBQX receptor antagonism, electron microscopy of synaptic vesicle size, measurement of readily releasable pool\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with electrophysiology, pharmacological dissection, and structural EM; multiple orthogonal endpoints\",\n      \"pmids\": [\"24904288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Bradykinin-induced glioma chemotaxis requires CaMKII-dependent activation of ClC-3: bradykinin raises intracellular Ca2+, activates Ca2+-dependent Cl- currents via CaMKII→ClC-3 and KCa3.1; pharmacological CaMKII inhibition or shRNA knockdown of ClC-3 each inhibit Ca2+-activated Cl- currents and abolish bradykinin-induced chemotaxis; ClC-3 and KCa3.1 co-localize to invading processes of glioma cells.\",\n      \"method\": \"Fura-2 Ca2+ imaging, perforated patch-clamp electrophysiology, CaMKII inhibition, ClC-3 shRNA knockdown, brain slice invasion assay, immunofluorescence co-localization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking Ca2+ signaling through CaMKII to ClC-3 activity and functional invasion readout\",\n      \"pmids\": [\"23345219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ClC-3 deficiency promotes intestinal epithelial cell apoptosis via the mitochondrial pathway and impairs Paneth cell function; ClC-3 interacts with voltage-dependent anion channel 1 (VDAC1, a regulator of mitochondrial cytochrome c release) by co-immunoprecipitation; DSS treatment decreases the ClC-3/VDAC1 interaction; ClC-3-/- mice show increased susceptibility to experimental colitis.\",\n      \"method\": \"Clcn3-/- knockout mice, dextran sulfate sodium/TNBS colitis models, co-immunoprecipitation of ClC-3 with VDAC1, apoptosis assays, Paneth cell counting, antimicrobial peptide expression\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with co-IP and multiple functional apoptosis/cellular readouts\",\n      \"pmids\": [\"24440986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Three ClC-3 splice variants (ClC-3a, -3b, -3c) differ in subcellular targeting but mediate identical Cl-/H+ exchange: ClC-3a/b target to late endosomes/lysosomes via N-terminal dileucine-like motifs; ClC-3c targets to recycling endosomes via a novel N-terminal isoleucine-proline (IP) motif; all three produce equivalent outwardly rectifying Cl- currents with capacitive components.\",\n      \"method\": \"Identification of splice variants in mouse brain, immunofluorescence co-localization with compartment markers, site-directed mutagenesis of trafficking motifs, whole-cell patch-clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — multiple isoforms characterized with mutagenesis of targeting motifs and electrophysiological functional validation\",\n      \"pmids\": [\"26342074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Angiotensin II-induced Cl- current in vascular smooth muscle cells requires ClC-3 channel phosphorylation at threonine 532 by Rho-kinase 2 (ROCK2): ROCK2 co-immunoprecipitates with ClC-3 N- and C-termini; ROCK2 siRNA abolishes AngII-induced current; T532D phosphomimetic mutant potentiates, while T532A abolishes, AngII-induced current and VSMC migration; AngII-induced cerebrovascular remodeling is reduced in ClC-3 null mice.\",\n      \"method\": \"Co-immunoprecipitation, N/C-terminal truncation constructs, site-directed mutagenesis (T532D, T532A), ROCK2 siRNA, whole-cell patch-clamp, transwell migration assay, ClC-3 null mice\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis + co-IP + genetic null with functional electrophysiology and migration readouts\",\n      \"pmids\": [\"26562480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ClC-4 sorting to endosomal compartments depends on its preferred heterodimerization with ClC-3: ClC-4 expressed alone is retained in ER; co-expression with ClC-3 splice variants redirects ClC-4 to late endosomes/lysosomes or recycling endosomes depending on which ClC-3 isoform is present; in Clcn3-/- astrocytes, ClC-4 is retained in the ER; high-resolution clear native PAGE shows ClC-3-ClC-4 heterodimers are more stable than ClC-4 homodimers.\",\n      \"method\": \"Heterologous co-expression, immunofluorescence co-localization, Clcn3-/- astrocytes, high-resolution clear native gel electrophoresis for oligomeric state analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic null confirmation plus biochemical oligomerization analysis with defined functional trafficking readout\",\n      \"pmids\": [\"28972156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Detailed mechanistic analysis of ClC-3 Cl-/H+ exchange: the external gating glutamate E224 and central tyrosine anion gate Y572 act as anion barriers and interact to form a 'closed gate' conformation that maintains coupling; Y572S removal increases uncoupled anion current and impairs coupling; M531A mutation predicted to improve water-wire H+ supply improves exchange efficiency; external protons (pH 5.0) inhibit transport and shift gating charge; ClC-3 has lower transport efficiency but identical coupling ratio compared to ClC-5.\",\n      \"method\": \"Plasma membrane-localized ClC-3, whole-cell patch-clamp, pH manipulation, gating charge (Q) analysis, cytoplasmic alkalization rate measurement, multiple mutagenesis (E224A, Y572S, Y572F, M531A)\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis of multiple gating residues with quantitative biophysical analysis of coupling, Q movement, and transport rates\",\n      \"pmids\": [\"29917234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ClC-3 Cl-/H+ transporter regulates HER2 transcription in HER2-positive breast cancer cells through STAT3 signaling: ClC-3 siRNA knockdown in MDA-MB-453 cells markedly represses HER2 transcription and decreases STAT3 phosphorylation while increasing AKT phosphorylation.\",\n      \"method\": \"siRNA knockdown of ClC-3, qPCR and Western blot for HER2, phospho-AKT and phospho-STAT3 analysis, kinase inhibitors (AZD5363, everolimus, 5,15-DPP)\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — siRNA with pathway readouts, single lab, limited mechanistic detail on direct ClC-3/STAT3 link\",\n      \"pmids\": [\"29949674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ClC-3 promotes angiotensin II-induced NADPH oxidase activation and ROS production in endothelial cells by facilitating Nox2/p22phox expression and p38 MAPK-dependent phosphorylation and membrane translocation of p47phox/p67phox to form the Nox2 NADPH oxidase complex.\",\n      \"method\": \"ClC-3 knockdown/overexpression in HUVECs, NADPH oxidase activity assay, ROS measurement, p47phox/p67phox membrane fractionation, p38 MAPK inhibitor SB203580, Western blot for complex components\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function and loss-of-function with mechanistic dissection of NADPH oxidase complex formation; single lab\",\n      \"pmids\": [\"29977005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo heterozygous missense variants and homozygous loss-of-function variants in CLCN3 cause neurodevelopmental disorders with GDD/ID and structural brain abnormalities; two missense variants (p.Ile607Thr and p.Thr570Ile) show increased currents at negative cytoplasmic voltages and loss of inhibition by luminal acidic pH in Xenopus oocytes and mammalian cells, demonstrating gain-of-function alterations in Cl-/H+ exchange gating.\",\n      \"method\": \"Whole-exome sequencing, electrophysiological characterization of variants in Xenopus oocytes and mammalian cells, clinical neuroimaging (MRI)\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — direct functional electrophysiological characterization of patient variants in established expression systems; links specific variant mechanisms to human disease\",\n      \"pmids\": [\"34186028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"VSMC migration requires ClC-3-dependent Ca2+-activated Cl- current (ICl.Ca): ICl.Ca is reduced ~50% in ClC-3 null VSMCs; the ClC-3-dependent component is activated by CaMKII (inhibited by KN-93) and inhibited by Ins(3,4,5,6)P4; ClC-3 null VSMCs show ~50% reduced migration in transwell assays; wild-type cell migration is reduced by niflumic acid, KN-93, or Ins(3,4,5,6)P4 but not in ClC-3 null cells.\",\n      \"method\": \"Whole-cell patch-clamp in WT and ClC-3 null VSMCs, CaMKII inhibitor, Ins(3,4,5,6)P4, transwell migration assay, Clcn3-/- genetic knockout\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic null combined with pharmacological dissection linking specific kinase/second-messenger regulation to ClC-3-dependent migration\",\n      \"pmids\": [\"23150504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Cardiac-specific inducible ClC-3 knockout eliminates native VSOAC currents in atrial and ventricular myocytes and causes myocardial hypertrophy and heart failure, establishing ClC-3 as the key molecular component of native VSOACs in mammalian heart and demonstrating a cardioprotective role.\",\n      \"method\": \"Inducible cardiac-specific Cre/lox ClC-3 knockout mice, echocardiography, patch-clamp of isolated cardiomyocytes, qRT-PCR and Western blot for ClC-3 loss\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible, tissue-specific genetic knockout with direct electrophysiological and cardiac function readouts\",\n      \"pmids\": [\"19615374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HNRNPK is identified as a transcription factor that directly binds the CLCN3 promoter (binding motif 'GCGAGG', binding site -538/-248 bp) and drives CLCN3 transcription; HNRNPK knockdown suppresses CLCN3 promoter activity and mRNA/protein expression; reduced extracellular ClC-3 secretion from HNRNPK-silenced cells inhibits cancer-associated fibroblast (CAF) activation and TGF-β1 production.\",\n      \"method\": \"5'-biotin-labeled promoter pulldown assay to identify HNRNPK, promoter activity reporter assays, shRNA knockdown, RNA-seq, xenograft mouse model, CAF isolation and functional assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter pulldown identifies transcription factor with mutagenesis of binding site and functional reporter assay; single lab\",\n      \"pmids\": [\"36439880\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CLCN3 encodes an intracellular Cl-/H+ antiporter (ClC-3) that primarily localizes to endosomes, lysosomes, synaptic vesicles, and insulin secretory granules via AP-3- and clathrin-dependent trafficking (directed by N-terminal dileucine and isoform-specific targeting motifs); it provides charge compensation for V-ATPase-driven organelle acidification critical for lysosomal degradation, synaptic vesicle neurotransmitter loading (both GABAergic and glutamatergic), and insulin granule priming; at the plasma membrane, ClC-3 is activated by CaMKII phosphorylation at S109 (and regulated by ROCK2 at T532 and PKC at S51) to mediate volume-sensitive Cl- efflux supporting cell volume regulation, premitotic condensation, and cell migration; ClC-3 also functions within signaling endosomes to provide charge neutralization for Nox1 NADPH oxidase-generated electron flow, enabling ROS-dependent NF-κB activation downstream of TNF-α/IL-1β; loss-of-function variants in humans cause neurodevelopmental disorders, while gain-of-function variants alter Cl-/H+ coupling gating.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLCN3 encodes ClC-3, an intracellular Cl⁻/H⁺ antiporter that provides charge compensation for V-ATPase-driven acidification of endosomes, lysosomes, synaptic vesicles, and insulin secretory granules, thereby supporting lysosomal degradation, neurotransmitter loading, and insulin granule priming [PMID:12059962, PMID:21378974, PMID:19808023, PMID:17977943]. ClC-3 splice variants are differentially targeted to late endosomes/lysosomes or recycling endosomes via N-terminal dileucine and isoleucine-proline motifs through clathrin- and AP-3-dependent trafficking, and ClC-3 heterodimerizes with ClC-4 to direct ClC-4 compartmental sorting [PMID:26342074, PMID:17652080, PMID:15073168, PMID:28972156]. At the plasma membrane, CaMKII phosphorylation at S109 and ROCK2 phosphorylation at T532 activate ClC-3-mediated Cl⁻ efflux that drives cell volume regulation, premitotic cytoplasmic condensation, and cell migration, while within signaling endosomes ClC-3 provides charge neutralization for Nox1-dependent ROS production and downstream NF-κB activation [PMID:14754994, PMID:26562480, PMID:18784301, PMID:17673675]. De novo missense and homozygous loss-of-function variants in CLCN3 cause neurodevelopmental disorders with global developmental delay, intellectual disability, and structural brain abnormalities [PMID:34186028].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Cloning of CLCN3 established it as a member of the voltage-gated chloride channel family with predominant expression in neuroectoderm-derived tissues, raising the question of its physiological ion transport role.\",\n      \"evidence\": \"Molecular cloning, sequence analysis, and Northern blot/in situ hybridization in human tissues\",\n      \"pmids\": [\"7665160\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional electrophysiology performed\", \"Endogenous subcellular localization not determined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of PKC phosphorylation at S51 as a volume-sensing regulatory mechanism and CaMKII as an activator established that ClC-3 channel activity is under bidirectional kinase control at the plasma membrane.\",\n      \"evidence\": \"Site-directed mutagenesis and patch-clamp in cardiac cells and NIH/3T3 overexpression systems; CaMKII infusion in tsA cells with surface biotinylation\",\n      \"pmids\": [\"9874688\", \"11274166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CaMKII phosphorylation site was identified at this stage\", \"Physiological context of dual kinase regulation unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Heterologous expression revealed ClC-3 produces extremely outward-rectifying, swelling-insensitive currents identical to ClC-5, challenging the simple model that ClC-3 is the canonical volume-sensitive anion channel.\",\n      \"evidence\": \"Transient transfection in CHO-K1 cells with whole-cell patch-clamp and pharmacological profiling\",\n      \"pmids\": [\"10973952\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apparent conflict with endogenous VSOAC data not resolved\", \"Cell-type-specific differences in ClC-3 function not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Multiple convergent studies established ClC-3 as a predominantly intracellular protein required for endosomal/lysosomal acidification: Clcn3⁻/⁻ mice showed elevated endosomal pH, neuronal ceroid lipofuscinosis-like neurodegeneration, and lysosomal storage, while overexpression promoted LAMP-1-positive acidic vesicle formation dependent on the E224 gating glutamate.\",\n      \"evidence\": \"Targeted gene disruption in mice with endosomal pH measurement and histology; heterologous overexpression with E224A mutagenesis and lysosomal marker co-localization\",\n      \"pmids\": [\"12059962\", \"11997263\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of V-ATPase coupling not biochemically defined\", \"Relative contribution of Cl⁻ channel vs. antiporter mode not yet resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"AP-3-dependent sorting to synaptic vesicles was demonstrated using the mocha mouse model, linking ClC-3 trafficking to presynaptic function and vesicular zinc transport alongside ZnT3.\",\n      \"evidence\": \"AP-3-deficient mocha mice, subcellular fractionation, brefeldin A treatment, ZnT3 co-fractionation and zinc transport assay in PC-12 cells\",\n      \"pmids\": [\"15073168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct role in neurotransmitter loading not yet tested\", \"Relative contribution of AP-3 vs. clathrin pathways not quantified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of S109 as the specific CaMKII phosphorylation site responsible for plasma membrane Cl⁻ conductance activation provided a defined molecular mechanism for kinase-dependent ClC-3 regulation.\",\n      \"evidence\": \"In vitro kinase assay, S109A mutagenesis, whole-cell patch-clamp with CaMKII infusion in smooth muscle and HT29 cells, Clcn3⁻/⁻ negative control\",\n      \"pmids\": [\"14754994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether S109 phosphorylation alters trafficking versus gating not distinguished\", \"In vivo phosphorylation stoichiometry unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Several key mechanistic features were resolved simultaneously: (1) ClC-3 operates as a coupled Cl⁻/H⁺ antiporter gated by the E224 glutamate, (2) clathrin-mediated endocytosis via an N-terminal dileucine motif keeps ClC-3 predominantly intracellular, (3) ClC-3 in signaling endosomes provides charge neutralization for Nox1 NADPH oxidase enabling TNFα/IL-1β-induced ROS production and NF-κB activation, and (4) F-actin binding to the C-terminus is required for hypotonic activation.\",\n      \"evidence\": \"Overexpression with pH manipulation and E224A mutagenesis for antiport; co-IP and mutagenesis of dileucine motif for trafficking; co-IP with Nox1, shRNA, and NF-κB reporter for endosomal ROS; GST pulldown with F-actin and peptide competition with patch-clamp for cytoskeletal interaction\",\n      \"pmids\": [\"17977943\", \"17652080\", \"17673675\", \"17442672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Cl⁻/H⁺ coupling unknown\", \"How Nox1-ClC-3 coupling is regulated remains unclear\", \"F-actin interaction domain not structurally characterized\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"ClC-3 was shown to participate in diverse cellular processes beyond ion transport: premitotic cytoplasmic condensation during cell division, CaMKII-dependent glioma invasion, endosomal-dependent exocytosis in chromaffin cells, postsynaptic modulation of NMDA receptor responses, and cardiac VSOAC activity essential for cardioprotection.\",\n      \"evidence\": \"Patch-clamp at defined cell cycle stages with shRNA; co-IP of ClC-3 with CaMKII in glioma biopsies and invasion assays; Clcn3⁻/⁻ chromaffin cell capacitance measurements; co-IP with NMDA receptors and surface biotinylation in hippocampal neurons with Clcn3⁻/⁻ comparison; cardiac-specific inducible knockout with echocardiography\",\n      \"pmids\": [\"18784301\", \"20139089\", \"18923035\", \"17046694\", \"19615374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of ClC-3/NMDA receptor interaction not defined\", \"Whether cardiac hypertrophy is directly due to loss of volume regulation or secondary effects unknown\", \"Mechanism linking endosomal ClC-3 to LDCV exocytosis indirect\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Two studies defined the biophysical basis and physiological scope of ClC-3 antiport: pH-dependent uncoupling of Cl⁻/H⁺ exchange at low luminal pH was characterized, and ClC-3 on insulin secretory granules was shown essential for granule acidification and priming, with >60% reduction in insulin secretion in Clcn3⁻/⁻ beta cells.\",\n      \"evidence\": \"Systematic pH manipulation with E224A and cysteine mutagenesis in HEK293 cells; Clcn3⁻/⁻ beta cells with insulin secretion assays, capacitance measurements, and immuno-EM of LDCVs\",\n      \"pmids\": [\"19926787\", \"19808023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of uncoupling at extreme pH not clear\", \"Whether impaired insulin secretion contributes to metabolic phenotype in vivo not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Presynaptic ClC-3 on GABAergic synaptic vesicles was shown essential for inhibitory neurotransmission by enabling Cl⁻-dependent vesicle acidification and GABA loading, while CaMKII-phosphorylated ClC-3 at postsynaptic sites was found to limit long-term potentiation magnitude.\",\n      \"evidence\": \"Hippocampal slice electrophysiology and vesicle acidification assays in Clcn3⁻/⁻ mice; LTP recordings with phospho-site decoy peptide\",\n      \"pmids\": [\"21378974\", \"23165767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ClC-3 is the sole vesicular Cl⁻/H⁺ exchanger on inhibitory SVs not resolved\", \"Mechanism by which postsynaptic ClC-3 constrains LTP expression unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"ClC-3 deficiency leads to larger synaptic vesicles with increased glutamate content and enhanced excitatory transmission, providing a mechanism for excitotoxic neurodegeneration, while in VSMCs ClC-3 was confirmed as necessary for CaMKII-dependent migration regulated by Ins(3,4,5,6)P4.\",\n      \"evidence\": \"Patch-clamp with γ-DGG antagonism and EM of SVs in Clcn3⁻/⁻ hippocampal neurons; ClC-3 null VSMCs with CaMKII inhibitor and Ins(3,4,5,6)P4 in transwell migration\",\n      \"pmids\": [\"24904288\", \"23150504\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether altered SV size is a direct consequence of antiport loss or secondary adaptation unknown\", \"How Ins(3,4,5,6)P4 binding inhibits ClC-3 structurally is undefined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Characterization of three ClC-3 splice variants revealed isoform-specific targeting motifs directing differential endosomal compartment sorting while preserving identical Cl⁻/H⁺ exchange, explaining how a single gene supports functions in multiple compartments.\",\n      \"evidence\": \"Splice variant identification in mouse brain, mutagenesis of N-terminal dileucine and IP motifs, co-localization with compartment markers, electrophysiology\",\n      \"pmids\": [\"26342074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative expression of each isoform across tissues not quantified\", \"Functional consequence of isoform-specific sorting in vivo not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"ROCK2 phosphorylation at T532 was identified as a third kinase regulatory input activating ClC-3 at the plasma membrane downstream of angiotensin II, linking ClC-3 to vascular remodeling.\",\n      \"evidence\": \"Co-IP, T532D/T532A mutagenesis, ROCK2 siRNA, patch-clamp, transwell migration, ClC-3 null mice cerebrovascular phenotype\",\n      \"pmids\": [\"26562480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKC, CaMKII, and ROCK2 regulate ClC-3 cooperatively or independently at the same channels unknown\", \"Structural basis of T532 regulation not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"ClC-3 was established as the obligate heterodimerization partner directing ClC-4 out of the ER to endosomal compartments, revealing a non-cell-autonomous trafficking function.\",\n      \"evidence\": \"Heterologous co-expression, Clcn3⁻/⁻ astrocytes showing ClC-4 ER retention, clear native PAGE demonstrating stable ClC-3/ClC-4 heterodimers\",\n      \"pmids\": [\"28972156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ClC-3/ClC-4 heterodimers have altered transport properties versus homodimers not tested\", \"Stoichiometry of heterodimer not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Detailed gating analysis revealed that coupled Cl⁻/H⁺ exchange depends on interaction between the external gating glutamate E224 and the central tyrosine gate Y572, with low luminal pH inhibiting transport—establishing the molecular basis for self-limiting acidification.\",\n      \"evidence\": \"Systematic mutagenesis (E224A, Y572S, Y572F, M531A) with gating charge analysis and cytoplasmic alkalization rate measurement\",\n      \"pmids\": [\"29917234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of ClC-3 available\", \"Conformational dynamics of gate interaction not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Human genetic evidence directly linked CLCN3 to neurodevelopmental disease: both loss-of-function and gain-of-function missense variants (p.Ile607Thr, p.Thr570Ile showing increased currents and loss of pH inhibition) cause GDD/ID with brain malformations, demonstrating bidirectional sensitivity to ClC-3 dysfunction.\",\n      \"evidence\": \"Whole-exome sequencing in affected families, electrophysiological characterization of variants in Xenopus oocytes and mammalian cells, clinical MRI\",\n      \"pmids\": [\"34186028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pathogenic mechanism of gain-of-function variants at the cellular level not defined\", \"Genotype-phenotype correlation across variant spectrum incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the high-resolution structure of ClC-3, the structural basis of Ins(3,4,5,6)P4 inhibition, how ClC-3 coordinates with V-ATPase stoichiometrically in different vesicle types, and whether gain-of-function and loss-of-function CLCN3 variants cause neurodegeneration through shared or distinct cellular mechanisms.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No cryo-EM or X-ray structure of ClC-3\", \"Ins(3,4,5,6)P4 binding site not mapped\", \"In vivo isoform-specific functions not dissected with conditional knockouts\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 2, 3, 4, 12, 20, 22, 33]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [5, 6, 21, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [5, 6, 14, 19, 22, 30]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [5, 6, 30]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [8, 19, 21, 24]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 10, 11, 13, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 2, 3, 4, 10, 12, 20, 22, 33]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [11, 24, 26, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [14, 23, 31, 35]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 13, 30, 32]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [17, 25]}\n    ],\n    \"complexes\": [\n      \"ClC-3/ClC-4 heterodimer\"\n    ],\n    \"partners\": [\n      \"CLCN4\",\n      \"CAMK2A\",\n      \"ROCK2\",\n      \"EBP50\",\n      \"VDAC1\",\n      \"GRIN1\",\n      \"AP3B1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}